Select Medical 10-Q 31 Oct 13 2013 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2013	Oct. 15, 2013
Document and Entity Information	'	'
Entity Registrant Name	'SELECT MEDICAL HOLDINGS CORP	'
Entity Central Index Key	'0001320414	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-13	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--12-31	'
Entity Current Reporting Status	'Yes	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	139,546,090
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'Q3	'

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified
Current Assets:	'	'	'	'
Cash and cash equivalents	$9,293	$40,144	$49,676	$12,043
Accounts receivable, net of allowance for doubtful accounts of $41,854 and $41,255 at 2012 and 2013, respectively	423,334	359,929	'	'
Current deferred tax asset	15,372	17,877	'	'
Prepaid income taxes	4,044	3,895	'	'
Other current assets	39,968	31,818	'	'
Total Current Assets	492,011	453,663	'	'
Property and equipment, net	499,531	501,552	'	'
Goodwill	1,641,836	1,640,534	'	'
Other identifiable intangibles	71,831	71,745	'	'
Other assets	137,215	93,867	'	'
Total Assets	2,842,424	2,761,361	2,781,808	'
Current Liabilities:	'	'	'	'
Bank overdrafts	7,435	17,836	'	'
Current portion of long-term debt and notes payable	13,966	11,646	'	'
Accounts payable	96,360	89,547	'	'
Accrued payroll	81,303	88,586	'	'
Accrued vacation	57,328	55,714	'	'
Accrued interest	22,005	22,016	'	'
Accrued other	102,925	102,040	'	'
Due to third party payors	3,968	1,078	'	'
Total Current Liabilities	385,290	388,463	'	'
Long-term debt, net of current portion	1,474,915	1,458,597	'	'
Non-current deferred tax liability	90,859	89,510	'	'
Other non-current liabilities	80,077	68,502	'	'
Total Liabilities	2,031,141	2,005,072	'	'
Redeemable non-controlling interests	11,623	10,811	'	'
Stockholders' Equity:	'	'	'	'
Common stock	140	141	'	'
Capital in excess of par	472,080	473,697	'	'
Retained earnings (accumulated deficit)	296,196	243,210	'	'
Total Select Medical Holdings Corporation and Select Medical Corporation Stockholders' Equity	768,416	717,048	'	'
Non-controlling interest	31,244	28,430	'	'
Total Equity	799,660	745,478	'	'
Total Liabilities and Equity	2,842,424	2,761,361	'	'
Select	'	'	'	'
Current Assets:	'	'	'	'
Cash and cash equivalents	9,293	40,144	49,676	12,043
Accounts receivable, net of allowance for doubtful accounts of $41,854 and $41,255 at 2012 and 2013, respectively	423,334	359,929	'	'
Current deferred tax asset	15,372	17,877	'	'
Prepaid income taxes	4,044	3,895	'	'
Other current assets	39,968	31,818	'	'
Total Current Assets	492,011	453,663	'	'
Property and equipment, net	499,531	501,552	'	'
Goodwill	1,641,836	1,640,534	'	'
Other identifiable intangibles	71,831	71,745	'	'
Other assets	137,215	92,819	'	'
Total Assets	2,842,424	2,760,313	2,780,678	'
Current Liabilities:	'	'	'	'
Bank overdrafts	7,435	17,836	'	'
Current portion of long-term debt and notes payable	13,966	11,646	'	'
Accounts payable	96,360	89,547	'	'
Accrued payroll	81,303	88,586	'	'
Accrued vacation	57,328	55,714	'	'
Accrued interest	22,005	18,759	'	'
Accrued other	102,925	107,280	'	'
Due to third party payors	3,968	1,078	'	'
Total Current Liabilities	385,290	390,446	'	'
Long-term debt, net of current portion	1,474,915	1,291,297	'	'
Non-current deferred tax liability	90,859	89,510	'	'
Other non-current liabilities	80,077	68,502	'	'
Total Liabilities	2,031,141	1,839,755	'	'
Redeemable non-controlling interests	11,623	10,811	'	'
Stockholders' Equity:	'	'	'	'
Common stock	0	0	'	'
Capital in excess of par	866,423	859,839	'	'
Retained earnings (accumulated deficit)	-98,007	21,478	'	'
Total Select Medical Holdings Corporation and Select Medical Corporation Stockholders' Equity	768,416	881,317	'	'
Non-controlling interest	31,244	28,430	'	'
Total Equity	799,660	909,747	'	'
Total Liabilities and Equity	$2,842,424	$2,760,313	'	'

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, except Share data, unless otherwise specified
Accounts receivable, allowance for doubtful accounts (in dollars)	$41,255	$41,854
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	700,000,000	700,000,000
Common stock, shares issued	139,546,090	140,589,256
Common stock, shares outstanding	139,546,090	140,589,256
Select	'	'
Accounts receivable, allowance for doubtful accounts (in dollars)	$41,255	$41,854
Common stock, par value (in dollars per share)	$0.01	$0.01
Common stock, shares issued	100	100
Common stock, shares outstanding	100	100

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	3 Months Ended			9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Mar. 31, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Net operating revenues	$722,845	'	$713,669	$2,229,473	$2,207,883
Costs and expenses:	'	'	'	'	'
Cost of services	617,281	'	598,984	1,867,915	1,823,272
General and administrative	17,740	'	17,130	53,065	49,908
Bad debt expense	9,262	'	11,199	27,429	31,603
Depreciation and amortization	16,163	'	15,537	47,872	47,164
Total costs and expenses	660,446	'	642,850	1,996,281	1,951,947
Income from operations	62,399	'	70,819	233,192	255,936
Other income and expense:	'	'	'	'	'
Loss on early retirement of debt	'	-1,500	-6,064	-18,747	-6,064
Equity in earnings (losses) of unconsolidated subsidiaries	-179	'	1,167	1,447	6,384
Interest expense	-21,252	'	-24,575	-66,614	-72,295
Income before income taxes	40,968	'	41,347	149,278	183,961
Income tax expense	15,761	'	16,189	57,391	71,415
Net income	25,207	'	25,158	91,887	112,546
Less: Net income attributable to non-controlling interests	1,935	'	1,048	6,417	3,722
Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation	23,272	'	24,110	85,470	108,824
Income per common share:	'	'	'	'	'
Basic (in dollars per share)	$0.17	'	$0.17	$0.61	$0.77
Diluted (in dollars per share)	$0.17	'	$0.17	$0.61	$0.77
Select	'	'	'	'	'
Net operating revenues	722,845	'	713,669	2,229,473	2,207,883
Costs and expenses:	'	'	'	'	'
Cost of services	617,281	'	598,984	1,867,915	1,823,272
General and administrative	17,740	'	17,130	53,065	49,908
Bad debt expense	9,262	'	11,199	27,429	31,603
Depreciation and amortization	16,163	'	15,537	47,872	47,164
Total costs and expenses	660,446	'	642,850	1,996,281	1,951,947
Income from operations	62,399	'	70,819	233,192	255,936
Other income and expense:	'	'	'	'	'
Loss on early retirement of debt	'	'	-6,064	-17,788	-6,064
Equity in earnings (losses) of unconsolidated subsidiaries	-179	'	1,167	1,447	6,384
Interest expense	-21,252	'	-21,740	-64,204	-63,947
Income before income taxes	40,968	'	44,182	152,647	192,309
Income tax expense	15,761	'	17,181	58,570	74,337
Net income	25,207	'	27,001	94,077	117,972
Less: Net income attributable to non-controlling interests	1,935	'	1,048	6,417	3,722
Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation	$23,272	'	$25,953	$87,660	$114,250

Consolidated_Statements_of_Cha

Consolidated Statements of Changes in Equity and Income (USD $)

Total

Select

Comprehensive Income

Comprehensive Income

Common Stock

Common Stock

Capital in Excess of Par

Capital in Excess of Par

Retained Earnings (accumulated deficit)

Retained Earnings (accumulated deficit)

Non-controlling Interests

Non-controlling Interests

In Thousands, unless otherwise specified

Select

Select

Select

Select

Select

Balance at Dec. 31, 2012

$745,478

$909,747

'

'

$141

$0

$473,697

$859,839

$243,210

$21,478

$28,430

$28,430

Balance (in shares) at Dec. 31, 2012

'

'

'

'

140,589

0

'

'

'

'

'

'

Increase (Decrease) in Stockholders' Equity

'

'

'

'

'

'

'

'

'

'

'

'

Net income

89,588

91,778

89,588

91,778

'

'

'

'

85,470

87,660

4,118

4,118

Net income - attributable to redeemable non-controlling interests

'

'

2,299

2,299

'

'

'

'

'

'

'

'

Total comprehensive income

'

'

91,887

94,077

'

'

'

'

'

'

'

'

Issuance and vesting of restricted stock

4,695

'

'

'

0

'

4,695

'

'

'

'

'

Issuance and vesting of restricted stock (in shares)

'

'

'

'

72

'

'

'

'

'

'

'

Stock option expense

708

'

'

'

'

'

708

'

'

'

'

'

Repurchase of common shares

-10,946

'

'

'

-1

'

-7,020

'

-3,925

'

'

'

Repurchase of common shares (in shares)

'

'

'

'

-1,115

'

'

'

'

'

'

'

Federal tax benefit of losses contributed by Holdings

'

1,181

'

'

'

'

'

1,181

'

'

'

'

Net change in dividends payable to Holdings

'

5,239

'

'

'

'

'

'

'

5,239

'

'

Dividends declared and paid

-27,929

-211,754

'

'

'

'

'

'

-27,929

-211,754

'

'

Contribution related to restricted stock awards and stock option issuances by Holdings

'

5,403

'

'

'

'

'

5,403

'

'

'

'

Acquisitions of non-controlling interests

261

261

'

'

'

'

'

'

'

'

261

261

Distributions to non-controlling interests

-1,565

-1,565

'

'

'

'

'

'

'

'

-1,565

-1,565

Redeemable non-controlling interests redemption value adjustment

-630

-630

'

'

'

'

'

'

-630

-630

'

'

Balance at Sep. 30, 2013

$799,660

$799,660

'

'

$140

$0

$472,080

$866,423

$296,196

($98,007)

$31,244

$31,244

Balance (in shares) at Sep. 30, 2013

'

'

'

'

139,546

0

'

'

'

'

'

'

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Operating activities	'	'
Net income	$91,887	$112,546
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	47,872	47,164
Provision for bad debts	27,429	31,603
Equity in earnings of unconsolidated subsidiaries	-1,447	-6,384
Loss on early retirement of debt	18,747	6,064
Gain from disposal or sale of assets	-93	-3,484
Non-cash stock compensation expense	5,403	3,990
Amortization of debt discount and issuance costs	6,507	5,494
Changes in operating assets and liabilities, net of effects from acquisition of businesses:	'	'
Accounts receivable	-89,237	-10,507
Other current assets	-7,642	-1,849
Other assets	-3,211	1,270
Accounts payable	6,798	-4,098
Due to third-party payors	2,890	360
Accrued expenses	4,788	348
Income and deferred taxes	4,414	11,559
Net cash provided by operating activities	115,105	194,076
Investing activities	'	'
Purchases of property and equipment	-45,331	-45,188
Proceeds from sale of assets	518	16,511
Investment in businesses, net of distributions	-32,430	-9,899
Acquisition of businesses, net of cash acquired	-848	-1,547
Net cash used in investing activities	-78,091	-40,123
Financing activities	'	'
Borrowings on revolving credit facility	580,000	365,000
Payments on revolving credit facility	-645,000	-405,000
Borrowings on credit facility term loans, net of discount	298,500	266,750
Payments on credit facility term loans	-594,668	-7,063
Issuance of 6.375% senior notes	600,000	'
Repurchase of senior floating rate notes	-167,300	'
Repurchase of 7 5/8% senior subordinated notes	-70,000	-278,495
Borrowings of other debt	9,238	5,835
Principal payments on other debt	-7,467	-7,417
Debt issuance costs	-18,820	-4,236
Dividends paid	-27,929	'
Repurchase of common stock	-10,946	-46,790
Proceeds from issuance of common stock	'	1,104
Repayment of bank overdrafts	-10,401	-3,011
Distributions to non-controlling interests	-3,072	-2,997
Net cash used in financing activities	-67,865	-116,320
Net increase (decrease) in cash and cash equivalents	-30,851	37,633
Cash and cash equivalents at beginning of period	40,144	12,043
Cash and cash equivalents at end of period	9,293	49,676
Supplemental Cash Flow Information	'	'
Cash paid for interest	60,439	68,122
Cash paid for taxes	52,977	59,850
Select	'	'
Operating activities	'	'
Net income	94,077	117,972
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	47,872	47,164
Provision for bad debts	27,429	31,603
Equity in earnings of unconsolidated subsidiaries	-1,447	-6,384
Loss on early retirement of debt	17,788	6,064
Gain from disposal or sale of assets	-93	-3,484
Non-cash stock compensation expense	5,403	3,990
Amortization of debt discount and issuance costs	6,418	5,215
Changes in operating assets and liabilities, net of effects from acquisition of businesses:	'	'
Accounts receivable	-89,237	-10,507
Other current assets	-7,642	-1,849
Other assets	-3,211	1,270
Accounts payable	6,798	-4,098
Due to third-party payors	2,890	360
Accrued expenses	8,046	2,956
Income and deferred taxes	5,593	14,481
Net cash provided by operating activities	120,684	204,753
Investing activities	'	'
Purchases of property and equipment	-45,331	-45,188
Proceeds from sale of assets	518	16,511
Investment in businesses, net of distributions	-32,430	-9,899
Acquisition of businesses, net of cash acquired	-848	-1,547
Net cash used in investing activities	-78,091	-40,123
Financing activities	'	'
Borrowings on revolving credit facility	580,000	365,000
Payments on revolving credit facility	-645,000	-405,000
Borrowings on credit facility term loans, net of discount	298,500	266,750
Payments on credit facility term loans	-594,668	-7,063
Issuance of 6.375% senior notes	600,000	'
Repurchase of 7 5/8% senior subordinated notes	-70,000	-278,495
Borrowings of other debt	9,238	5,835
Principal payments on other debt	-7,467	-7,417
Debt issuance costs	-18,820	-4,236
Dividends paid	-211,754	-57,467
Equity investment by Holdings	'	1,104
Repayment of bank overdrafts	-10,401	-3,011
Distributions to non-controlling interests	-3,072	-2,997
Net cash used in financing activities	-73,444	-126,997
Net increase (decrease) in cash and cash equivalents	-30,851	37,633
Cash and cash equivalents at beginning of period	40,144	12,043
Cash and cash equivalents at end of period	9,293	49,676
Supplemental Cash Flow Information	'	'
Cash paid for interest	54,860	57,448
Cash paid for taxes	$52,977	$59,850

Consolidated_Statements_of_Cas1

Consolidated Statements of Cash Flows (Parenthetical)	Sep. 30, 2013	Dec. 31, 2012
7 5/8% senior subordinated notes	'	'
Long-Term Debt and Notes Payable	'	'
Interest rate of debt (as a percent)	7.63%	7.63%
6.375% senior notes	'	'
Long-Term Debt and Notes Payable	'	'
Interest rate of debt (as a percent)	6.38%	'

Basis_of_Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2013
Basis of Presentation	'
Basis of Presentation	'
	1.              Basis of Presentation
	The unaudited consolidated financial statements of Select Medical Holdings Corporation (“Holdings”) and Select Medical Corporation (“Select”) as of September 30, 2013 and for the three and nine month periods ended September 30, 2012 and 2013 have been prepared in accordance with generally accepted accounting principles (“GAAP”).  In the opinion of management, such information contains all adjustments, which are normal and recurring in nature, necessary for a fair statement of the financial position, results of operations and cash flow for such periods.  All significant intercompany transactions and balances have been eliminated.  The results of operations for the three and nine months ended September 30, 2013 are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2013.  Holdings and Select and their subsidiaries are collectively referred to as the “Company.” The consolidated financial statements of Holdings include the accounts of its wholly-owned subsidiary Select. Holdings conducts substantially all of its business through Select and its subsidiaries.
	Certain information and disclosures normally included in the notes to consolidated financial statements have been condensed or omitted consistent with the rules and regulations of the Securities and Exchange Commission (the “SEC”), although the Company believes the disclosure is adequate to make the information presented not misleading.   The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2012 contained in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 26, 2013.

Accounting_Policies

Accounting Policies	9 Months Ended
	Sep. 30, 2013
Accounting Policies	'
Accounting Policies	'
	2.              Accounting Policies
	Use of Estimates
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.

Intangible_Assets

Intangible Assets	9 Months Ended
	Sep. 30, 2013
Intangible Assets	'
Intangible Assets	'
	3.  Intangible Assets
	The gross carrying amounts of the Company’s indefinite-lived intangible assets consist of the following:
		December 31,		September 30,
		2012		2013
		(in thousands)
	Goodwill	$	1,640,534	$	1,641,836
	Trademarks	57,709		57,709
	Certificates of need	11,914		12,039
	Accreditations	2,122		2,083
	Total	$	1,712,279	$	1,713,667
	The Company’s accreditations and trademarks have renewal terms. The costs to renew these intangibles are expensed as incurred. At September 30, 2013, the accreditations and trademarks have a weighted average time until next renewal of approximately 1.5 years and 6.7 years, respectively.
	The changes in the carrying amount of goodwill for the Company’s reportable segments for the nine months ended September 30, 2013 are as follows:
		Specialty		Outpatient			Total
		Hospitals		Rehabilitation
		(in thousands)
	Balance as of December 31, 2012	$	1,333,220	$	307,314		$	1,640,534
	Goodwill acquired during the period	1,395		40			1,435
	Purchase price adjustment	—		(133		)	(133		)
	Balance as of September 30, 2013	$	1,334,615	$	307,221		$	1,641,836

Indebtedness

Indebtedness	9 Months Ended
	Sep. 30, 2013
Indebtedness	'
Indebtedness	'
	4.  Indebtedness
	The components of long-term debt and notes payable are as follows:
		Select Medical Holdings Corporation
		December 31,		September 30,
		2012		2013
		(in thousands)
	7 5/8% senior subordinated notes	$	70,000	$	—
	6.375% senior notes	—		600,000
	Senior secured credit facilities:
	Revolving loan	130,000		65,000
	Term loans (1)	1,096,641		809,438
	Senior floating rate notes	167,300		—
	Other	6,302		14,443
	Total debt	1,470,243		1,488,881
	Less: current maturities	11,646		13,966
	Total long-term debt	$	1,458,597	$	1,474,915
		Select Medical Corporation
		December 31,		September 30,
		2012		2013
		(in thousands)
	7 5/8% senior subordinated notes	$	70,000	$	—
	6.375% senior notes	—		600,000
	Senior secured credit facilities:
	Revolving loan	130,000		65,000
	Term loans (1)	1,096,641		809,438
	Other	6,302		14,443
	Total debt	1,302,943		1,488,881
	Less: current maturities	11,646		13,966
	Total long-term debt	$	1,291,297	$	1,474,915
	(1)         Presented net of unamortized discounts of $14.2 million and $6.8 million at December 31, 2012 and September 30, 2013, respectively.
	On February 20, 2013, Select entered into a credit extension amendment to its senior secured credit facilities providing for a $300.0 million additional term loan tranche, (the “series B term loan”) to Select.  Select used the borrowings under the series B term loan to redeem all of its outstanding 7 5/8% senior subordinated notes due 2015 on March 22, 2013, to finance Holdings’ redemption of all of its senior floating rate notes due 2015 on March 22, 2013 and to repay a portion of the balance outstanding under Select’s revolving credit facility.  The Company recognized a loss on early retirement of debt of $1.5 million during the three months ended March 31, 2013 for unamortized debt issuance costs, of which approximately $0.5 million was associated with Select’s 7 5/8% senior subordinated notes due 2015 and approximately $1.0 million was associated with Holdings’ senior floating rate notes due 2015.
	Borrowings under the series B term loan bear interest at a rate equal to Adjusted LIBO plus 3.25%, or Alternate Base Rate plus 2.25%.  The series B term loan amortizes in equal quarterly installments on the last day of each March, June, September and December in aggregate annual amounts equal to $3.0 million.  The balance of the series B term loan is payable on February 20, 2016.
	At the time of issuing the series B term loan, Select had additional term loan tranches outstanding including an $850.0 million term loan tranche issued on June 1, 2011 (the “original term loan”) and a $275.0 million incremental term loan tranche issued August 13, 2012 (the “series A term loan”). Both the original term loan and series A term loan tranches were issued at a discount and amortized in equal quarterly installments on the last day of each March, June, September and December. The balance of both the original term loan and series A term loan was payable on June 1, 2018.
	On May 28, 2013, Select issued and sold $600.0 million aggregate principal amount of its 6.375% senior notes due 2021.  On May 28, 2013, Select used the proceeds of the senior notes to pay a portion of the amounts then outstanding on the original term loan and the series A term loan, and to pay related fees and expenses.  Select recognized a loss on early retirement of debt of $17.3 million in the three months ended June 30, 2013 in connection with the repayment of a portion of its term loans and amendment of the existing senior secured credit facility, which included the write-off of unamortized debt issuance costs.
	Interest on the senior notes accrues at the rate of 6.375% per annum and is payable semi-annually in cash in arrears on June 1 and December 1 of each year, commencing on December 1, 2013.  The senior notes are Select’s senior unsecured obligations and rank equally in right of payment with all of its other existing and future senior unsecured indebtedness and senior in right of payment to all of its existing and future subordinated indebtedness.  The senior notes are unconditionally guaranteed by all of Select’s wholly-owned subsidiaries.  The senior notes are guaranteed, jointly and severally, by Select’s direct or indirect existing and future domestic restricted subsidiaries other than certain non-guarantor subsidiaries.
	Select may redeem some or all of the senior notes prior to June 1, 2016 by paying a “make-whole” premium.  Select may redeem some or all of the senior notes on or after June 1, 2016 at specified redemption prices.  In addition, prior to June 1, 2016, Select may redeem up to 35% of the senior notes with the net proceeds of certain equity offerings at a price of 106.375% plus accrued and unpaid interest, if any. Select is obligated to offer to repurchase the senior notes at a price of 101% of their principal amount plus accrued and unpaid interest, if any, as a result of certain change of control events.  These restrictions and prohibitions are subject to certain qualifications and exceptions.
	The Indenture relating to the senior notes contains covenants that, among other things, limit Select’s ability and the ability of certain of its subsidiaries to (i) grant liens on its assets, (ii) make dividend payments, other distributions or other restricted payments, (iii) incur restrictions on the ability of Select’s restricted subsidiaries to pay dividends or make other payments, (iv) enter into sale and leaseback transactions, (v) merge, consolidate, transfer or dispose of substantially all of their assets, (vi) incur additional indebtedness, (vii) make investments, (viii) sell assets, including capital stock of subsidiaries, (ix) use the proceeds from sales of assets, including capital stock of restricted subsidiaries, and (x) enter into transactions with affiliates.  In addition, the Indenture requires, among other things, Select to provide financial and current reports to holders of the senior notes or file such reports electronically with the U.S. Securities and Exchange Commission (the “SEC”).  These covenants are subject to a number of exceptions, limitations and qualifications set forth in the Indenture.
	On June 3, 2013, Select amended its existing senior secured credit facilities in order to:
	·                  extend the maturity date on $293.3 million of its $300.0 million revolving credit facility from June 1, 2016 to March 1, 2018;
	·                  convert the remaining original term loan and series A term loan to a series C term loan and lower the interest rate payable on the series C term loan from Adjusted LIBO plus 3.75%, or Alternate Base Rate plus 2.75%, to Adjusted LIBO plus 3.00%, or Alternate Base Rate plus 2.00%, and amend the provision of the series C term loan from providing that Adjusted LIBO will at no time be less than 1.75% to providing that Adjusted LIBO will at no time be less than 1.00%; and
	·                  amend the restrictive covenants governing the senior secured credit facilities in order to allow for unlimited restricted payments so long as there is no event of default under the senior secured credit facilities and the total pro forma ratio of total indebtedness to Consolidated EBITDA (as defined in our senior secured credit facilities) is less than or equal to 2.75 to 1.00.
	Maturities of Long-Term Debt and Notes Payable
	Maturities of the Company’s long-term debt for the period from October 1, 2013 through December 31, 2013 and the years after 2013 are approximately as follows and are presented net of the discounts on the senior secured credit facility term loans (in thousands):
	October 1, 2013 – December 31, 2013	$	4,869
	2014	11,497
	2015	10,086
	2016	296,134
	2017	4,075
	2018 and beyond	1,162,220

Fair_Value

Fair Value	9 Months Ended
	Sep. 30, 2013
Fair Value	'
Fair Value	'
	5.  Fair Value
	Financial instruments include cash and cash equivalents, notes payable and long-term debt.  The carrying amount of cash and cash equivalents approximates fair value because of the short-term maturity of these instruments.
	The carrying value of Select’s senior secured credit facility was $1,226.6 million and $874.4 million at December 31, 2012 and September 30, 2013, respectively.  The fair value of Select’s senior secured credit facility was $1,216.2 million and $867.9 million at December 31, 2012 and September 30, 2013, respectively.  The fair value of Select’s senior secured credit facility was based on quoted market prices for this debt in the syndicated loan market.
	The carrying value of Select’s 6.375% senior notes was $600.0 million at September 30, 2013.  The fair value of Select’s 6.375% senior notes was $570.0 million at September 30, 2013.  The fair value of this debt was based on quoted market prices.
	The Company considers the inputs in the valuation process of its senior secured credit facility and 6.375% senior notes to be Level 2 in the fair value hierarchy.  Level 2 in the fair value hierarchy is defined as inputs that are observable for the asset or liability, either directly or indirectly which includes quoted prices for identical assets or liabilities in markets that are not active.

Segment_Information

Segment Information	9 Months Ended
	Sep. 30, 2013
Segment Information	'
Segment Information	'
	6.  Segment Information
	The Company’s reportable segments consist of (i) specialty hospitals and (ii) outpatient rehabilitation. Other activities include the Company’s corporate services and certain other non-consolidating joint ventures and minority investments in other healthcare related businesses. The outpatient rehabilitation reportable segment has two operating segments: outpatient rehabilitation clinics and contract therapy. These operating segments are aggregated for reporting purposes as they have common economic characteristics and provide a similar service to a similar patient base. The accounting policies of the segments are the same as those described in the summary of significant accounting policies. The Company evaluates performance of the segments based on Adjusted EBITDA. Adjusted EBITDA is defined as net income before interest, income taxes, depreciation and amortization, gain (loss) on early retirement of debt, stock compensation expense, equity in earnings (losses) of unconsolidated subsidiaries and other income (expense).
	The following tables summarize selected financial data for the Company’s reportable segments. The segment results of Holdings are identical to those of Select with the exception of total assets:
		Three Months Ended September 30, 2012
		Specialty			Outpatient			Other			Total
		Hospitals			Rehabilitation
		(in thousands)
	Net operating revenues	$	531,409		$	182,246		$	14		$	713,669
	Adjusted EBITDA	83,659			20,354			(16,266		)	87,747
	Total assets:
	Select Medical Corporation	2,165,248			431,310			184,120			2,780,678
	Select Medical Holdings Corporation	2,165,248			431,310			185,250			2,781,808
	Capital expenditures	12,281			3,073			1,900			17,254
		Three Months Ended September 30, 2013
		Specialty			Outpatient			Other			Total
		Hospitals			Rehabilitation
		(in thousands)
	Net operating revenues	$	532,610		$	190,223		$	12		$	722,845
	Adjusted EBITDA	75,280			21,619			(16,471		)	80,428
	Total assets:
	Select Medical Corporation	2,232,756			445,729			163,939			2,842,424
	Select Medical Holdings Corporation	2,232,756			445,729			163,939			2,842,424
	Capital expenditures	14,157			2,802			410			17,369
		Nine Months Ended September 30, 2012
		Specialty			Outpatient			Other			Total
		Hospitals			Rehabilitation
		(in thousands)
	Net operating revenues	$	1,641,577		$	566,195		$	111		$	2,207,883
	Adjusted EBITDA	285,779			68,669			(47,358		)	307,090
	Total assets:
	Select Medical Corporation	2,165,248			431,310			184,120			2,780,678
	Select Medical Holdings Corporation	2,165,248			431,310			185,250			2,781,808
	Capital expenditures	31,963			9,786			3,439			45,188
		Nine Months Ended September 30, 2013
		Specialty			Outpatient			Other			Total
		Hospitals			Rehabilitation
		(in thousands)
	Net operating revenues	$	1,649,747		$	579,404		$	322		$	2,229,473
	Adjusted EBITDA	265,020			70,506			(49,059		)	286,467
	Total assets:
	Select Medical Corporation	2,232,756			445,729			163,939			2,842,424
	Select Medical Holdings Corporation	2,232,756			445,729			163,939			2,842,424
	Capital expenditures	35,257			8,646			1,428			45,331
	A reconciliation of Adjusted EBITDA to income before income taxes is as follows:
			Three Months Ended September 30, 2012
			Specialty					Outpatient			Other			Select			Select
			Hospitals					Rehabilitation						Medical			Medical
														Holdings			Corporation
														Corporation
			(in thousands)
	Adjusted EBITDA		$			83,659		$	20,354		$	(16,266	)
	Depreciation and amortization		(11,553				)	(3,152		)	(832		)
	Stock compensation expense		—					—			(1,391		)
	Income (loss) from operations		$		72,106			$	17,202		$	(18,489	)	$	70,819		$	70,819
	Loss on early retirement of debt													(6,064		)	(6,064		)
	Equity in earnings of unconsolidated subsidiaries													1,167			1,167
	Interest expense													(24,575		)	(21,740		)
	Income before income taxes													$	41,347		$	44,182
		Three Months Ended September 30, 2013
		Specialty			Outpatient			Other			Select			Select
		Hospitals			Rehabilitation						Medical			Medical
											Holdings			Corporation
											Corporation
	(in thousands)
Adjusted EBITDA	$	75,280		$	21,619		$	(16,471	)
Depreciation and amortization	(12,267		)	(2,979		)	(917		)
Stock compensation expense	—			—			(1,866		)
Income (loss) from operations	$	63,013		$	18,640		$	(19,254	)	$	62,399		$	62,399
Equity in losses of unconsolidated subsidiaries										(179		)	(179		)
Interest expense										(21,252		)	(21,252		)
Income before income taxes										$	40,968		$	40,968
			Nine Months Ended September 30, 2012
			Specialty				Outpatient			Other			Select			Select
			Hospitals				Rehabilitation						Medical			Medical
													Holdings			Corporation
													Corporation
			(in thousands)
Adjusted EBITDA			$		285,779		$	68,669		$	(47,358	)
Depreciation and amortization					(34,875	)		(10,034	)		(2,255	)
Stock compensation expense			—				—			(3,990		)
Income (loss) from operations		$			250,904		$	58,635		$	(53,603	)	$	255,936		$	255,936
Loss on early retirement of debt													(6,064		)	(6,064		)
Equity in earnings of unconsolidated subsidiaries													6,384			6,384
Interest expense													(72,295		)	(63,947		)
Income before income taxes													$	183,961		$	192,309
	Nine Months Ended September 30, 2013
	Specialty			Outpatient			Other			Select			Select
	Hospitals			Rehabilitation						Medical			Medical
										Holdings			Corporation
										Corporation
	(in thousands)
Adjusted EBITDA	$	265,020		$	70,506		$	(49,059	)
Depreciation and amortization	(36,061		)	(8,949		)	(2,862		)
Stock compensation expense	—			—			(5,403		)
Income (loss) from operations	$	228,959		$	61,557		$	(57,324	)	$	233,192		$	233,192
Equity in earnings of unconsolidated subsidiaries										1,447			1,447
Loss on early retirement of debt										(18,747		)	(17,788		)
Interest expense										(66,614		)	(64,204		)
Income before income taxes										$	149,278		$	152,647

Income_per_Common_Share

Income per Common Share	9 Months Ended
	Sep. 30, 2013
Income per Common Share	'
Income per Common Share	'
	7.  Income per Common Share
	The Company applies the two-class method for calculating and presenting income per common share. The two-class method is an earnings allocation formula that determines earnings per share for each class of stock participation rights in undistributed earnings. The following table sets forth for the periods indicated the calculation of income per common share in the Company’s consolidated statement of operations and the differences between basic weighted average shares outstanding and diluted weighted average shares outstanding used to compute basic and diluted income per common share, respectively:
		For the Three Months					For the Nine Months
		Ended September 30,					Ended September 30,
		2012			2013		2012		2013
		(in thousands, except per share amounts)
	Numerator:
	Net income attributable to Select Medical Holdings Corporation	$	24,110		$	23,272	$	108,824	$	85,470
	Less: Earnings allocated to unvested restricted stockholders	407			497		1,759		1,802
	Net income available to common stockholders	$	23,703		$	22,775	$	107,065	$	83,668
	Denominator:
	Weighted average shares — basic	137,551			136,646		139,138		136,879
	Effect of dilutive securities:
	Stock options	337			147		266		161
	Weighted average shares — diluted	137,888			136,793		139,404		137,040
	Basic income per common share	$	0.17		$	0.17	$	0.77	$	0.61
	Diluted income per common share	$	0.17		$	0.17	$	0.77	$	0.61
	The following share amounts are shown here for informational and comparative purposes only since their inclusion would be anti-dilutive:
		For the Three Months				For the Nine Months
		Ended September 30,				Ended September 30,
		2012		2013		2012	2013
		(in thousands)
	Stock options	78		1,477		1,683	1,528

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2013
Commitments and Contingencies	'
Commitments and Contingencies	'
	8. Commitments and Contingencies
	Litigation
	The Company is a party to various legal actions, proceedings and claims (some of which are not insured), and regulatory and other governmental audits and investigations in the ordinary course of its business. The Company cannot predict the ultimate outcome of pending litigation, proceedings and regulatory and other governmental audits and investigations. These matters could potentially subject the Company to sanctions, damages, recoupments, fines and other penalties. The Department of Justice, Centers for Medicare & Medicaid Services (“CMS”) or other federal and state enforcement and regulatory agencies may conduct additional investigations related to the Company’s businesses in the future that may, either individually or in the aggregate, have a material adverse effect on the Company’s business, financial position, results of operations and liquidity.
	To address claims arising out of the operations of the Company’s specialty hospitals and outpatient rehabilitation facilities, the Company maintains professional malpractice liability insurance and general liability insurance, subject to self-insured retention of $2.0 million per medical incident for professional liability claims and $2.0 million per occurrence for general liability claims. The Company also maintains umbrella liability insurance covering claims which, due to their nature or amount, are not covered by or not fully covered by the Company’s other insurance policies. These insurance policies also do not generally cover punitive damages and are subject to various deductibles and policy limits. Significant legal actions, as well as the cost and possible lack of available insurance, could subject the Company to substantial uninsured liabilities. In the Company’s opinion, the outcome of these actions, individually or in the aggregate, will not have a material adverse effect on its financial position, results of operations, or cash flows.
	Healthcare providers are subject to lawsuits under the qui tam provisions of the federal False Claims Act. Qui tam lawsuits typically remain under seal (hence, usually unknown to the defendant) for some time while the government decides whether or not to intervene on behalf of a private qui tam plaintiff (known as a relator) and take the lead in the litigation. These lawsuits can involve significant monetary damages and penalties and award bounties to private plaintiffs who successfully bring the suits. The Company has been a defendant in these cases in the past, and may be named as a defendant in similar cases from time to time in the future.
	On January 8, 2013, a federal magistrate judge unsealed an Amended Complaint in United States of America and the State of Indiana, ex rel. Doe I, Doe II and Doe III v. Select Medical Corporation, Select Specialty Hospital-Evansville, Evansville Physician Investment Corporation, Dr. Richard Sloan and Dr. Jeffrey Selby. The Amended Complaint, which was served on the Company on February 15, 2013, is a civil action filed under seal on September 28, 2012 in the United States District Court for the Southern District of Indiana by private plaintiff-relators on behalf of the United States and the state of Indiana under the federal False Claims Act and Indiana False Claims and Whistleblower Protection Act. Although the Amended Complaint identifies the relators by fictitious pseudonyms, on March 28, 2013, the relators filed a Notice identifying themselves as the former CEO at the Company’s long term acute care hospital in Evansville, Indiana (“SSH-Evansville”) and two former case managers at SSH-Evansville. The named defendants include the Company, SSH-Evansville, and two physicians who have practiced at SSH-Evansville. On March 26, 2013, the defendants, relators and the United States filed a joint motion seeking a stay of the proceedings, in which the United States notified the court that its investigation has not been completed and therefore it is not yet able to decide whether or not to intervene, and on March 29, 2013, the magistrate judge granted the motion and stayed all deadlines in the case for 90 days. On June 26, 2013, the United States filed a motion seeking to extend such stay of the proceedings for an additional 90 days, and, on August 12, 2013, the court granted the motion and stayed all deadlines in the case until October 1, 2013. On September 25, 2013, the United States filed a motion seeking to extend such stay for an additional 90 days.
	The Amended Complaint alleges that the defendants manipulated the length of stay of patients at SSH-Evansville in order to maximize reimbursement under the Medicare prospective payment system applicable to long term acute care hospitals. It also alleges that the defendants manipulated the discharge of patients to other facilities and the timing of readmissions from those facilities in order to enable SSH-Evansville to receive two separate Medicare payments and causing the other facility to submit claims for unnecessary services. The Amended Complaint discusses the federal Stark Law and Anti-Kickback Statute and implies that the behavior of physicians referring to or providing services at SSH-Evansville was based on their financial interests. The Amended Complaint further alleges that Dr. Selby, a pulmonologist formerly on the medical staff of SSH-Evansville, performed unnecessary bronchoscopies at the hospital with the knowledge of the Company, and that Dr. Sloan, the Chief Medical Officer and an attending physician at SSH-Evansville, falsely coded the diagnoses of Medicare patients in order to increase SSH-Evansville’s reimbursement. Moreover, the Amended Complaint alleges that the practices at SSH-Evansville involved corporate policies of the Company used to maximize profit at all Select long term acute care hospitals. The Amended Complaint alleges that, through these acts, the defendants have violated the federal False Claims Act and Indiana False Claims and Whistleblower Protection Act and are liable for unspecified treble damages and penalties.
	As previously disclosed, beginning in April 2012, the Company and SSH-Evansville have received various subpoenas and demands for documents relating to SSH-Evansville, including a request for information and subpoenas from the Office of Inspector General of the U.S. Department of Health and Human Services and subpoenas from the Office of Attorney General for the State of Indiana, and the Evansville (Indiana) Police Department has executed a search warrant at SSH-Evansville. The Company has produced and will continue to produce documents in response to, and intends to fully cooperate with, these governmental investigations. At this time, the Company is unable to predict the timing and outcome of this matter.
	Construction Commitments
	At September 30, 2013, the Company had outstanding commitments under construction contracts related to new construction, improvements and renovations at the Company’s long term acute care properties and inpatient rehabilitation facilities totaling approximately $15.3 million.

Subsequent_Event

Subsequent Event	9 Months Ended
	Sep. 30, 2013
Subsequent Event	'
Subsequent Event	'
	9.              Subsequent Event
	On October 30, 2013, Holdings’ board of directors declared a quarterly cash dividend of $0.10 per share. The dividend will be payable on or about November 22, 2013 to stockholders of record as of the close of business on November 12, 2013.

Financial_Information_for_Subs

Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 6.375% Senior Notes	9 Months Ended
	Sep. 30, 2013
Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 6.375% Senior Notes	'
Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 6.375% Senior Notes	'
	10.       Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select’s 6.375% Senior Notes
	Select’s 6.375% senior notes are fully and unconditionally guaranteed, except for customary limitations, on a senior basis by all of Select’s wholly-owned subsidiaries (the “Subsidiary Guarantors”) which is defined as a subsidiary where Select or a subsidiary of Select holds all of the outstanding ownership interests. Certain of Select’s subsidiaries did not guarantee the 6.375% senior notes (the “Non-Guarantor Subsidiaries”).
	Select conducts a significant portion of its business through its subsidiaries. Presented below is condensed consolidating financial information for Select, the Subsidiary Guarantors and the Non-Guarantor Subsidiaries at December 31, 2012 and September 30, 2013 and for the three and nine months ended September 30, 2012 and 2013.
	The equity method has been used by Select with respect to investments in subsidiaries. The equity method has been used by Subsidiary Guarantors with respect to investments in Non-Guarantor Subsidiaries. Separate financial statements for Subsidiary Guarantors are not presented.
	Select Medical Corporation
	Condensed Consolidating Balance Sheet
	September 30, 2013
	(unaudited)
		Select Medical			Subsidiary			Non-Guarantor			Eliminations			Consolidated
		Corporation (Parent			Guarantors			Subsidiaries
		Company Only)
		(in thousands)
	Assets
	Current Assets:
	Cash and cash equivalents	$	5,052		$	2,996		$	1,245		$	—		$	9,293
	Accounts receivable, net	—			360,805			62,529			—			423,334
	Current deferred tax asset	8,038			2,945			4,389			—			15,372
	Prepaid income taxes	4,044			—			—			—			4,044
	Intercompany receivables	—			1,034,542			100,930			(1,135,472		)(a)	—
	Other current assets	8,325			26,783			4,860			—			39,968
	Total Current Assets	25,459			1,428,071			173,953			(1,135,472		)	492,011
	Property and equipment, net	14,911			426,915			57,705			—			499,531
	Investment in affiliates	3,024,968			80,282			—			(3,105,250		)(b) (c)	—
	Goodwill	—			1,641,836			—			—			1,641,836
	Other identifiable intangibles	—			71,831			—			—			71,831
	Non-current deferred tax asset	8,097			—			—			(8,097		)(d)	—
	Other assets	36,509			100,113			593			—			137,215
	Total Assets	$	3,109,944		$	3,749,048		$	232,251		$	(4,248,819	)	$	2,842,424
	Liabilities and Equity
	Current Liabilities:
	Bank overdrafts	$	7,435		$	—		$	—		$	—		$	7,435
	Current portion of long-term debt and notes payable	9,467			1,918			2,581			—			13,966
	Accounts payable	7,554			75,452			13,354			—			96,360
	Intercompany payables	1,135,472			—			—			(1,135,472		)(a)	—
	Accrued payroll	516			80,527			260			—			81,303
	Accrued vacation	4,502			45,567			7,259			—			57,328
	Accrued interest	20,783			1,222			—			—			22,005
	Accrued other	52,028			41,525			9,372			—			102,925
	Due to third party payors	—			733			3,235			—			3,968
	Total Current Liabilities	1,237,757			246,944			36,061			(1,135,472		)	385,290
	Long-term debt, net of current portion	1,048,053			367,232			59,630			—			1,474,915
	Non-current deferred tax liability	—			89,222			9,734			(8,097		)(d)	90,859
	Other non-current liabilities	55,718			23,028			1,331			—			80,077
	Total Liabilities	2,341,528			726,426			106,756			(1,143,569		)	2,031,141
	Redeemable non-controlling interest	—			—			11,623			—			11,623
	Stockholder’s Equity:
	Common stock	0			—			—			—			0
	Capital in excess of par	866,423			—			—			—			866,423
	Retained earnings (accumulated deficit)	(98,007		)	886,099			18,438			(904,537		)(c)	(98,007		)
	Subsidiary investment	—			2,136,523			64,190			(2,200,713		)(b)	—
	Total Select Medical Corporation Stockholder’s Equity	768,416			3,022,622			82,628			(3,105,250		)	768,416
	Non-controlling interest	—			—			31,244			—			31,244
	Total Equity	768,416			3,022,622			113,872			(3,105,250		)	799,660
	Total Liabilities and Equity	$	3,109,944		$	3,749,048		$	232,251		$	(4,248,819	)	$	2,842,424
	(a)  Elimination of intercompany.
	(b)  Elimination of investments in consolidated subsidiaries.
	(c)  Elimination of investments in consolidated subsidiaries’ earnings.
	(d)  Reclass of non-current deferred tax asset to report net non-current deferred tax liability in consolidation.
	Select Medical Corporation
	Condensed Consolidating Statement of Operations
	For the Three Months Ended September 30, 2013
	(unaudited)
		Select Medical			Subsidiary			Non-			Eliminations			Consolidated
Corporation (Parent		Guarantors			Guarantor
Company Only)					Subsidiaries
	(in thousands)
Net operating revenues	$	12		$	617,415		$	105,418		$	—		$	722,845
Costs and expenses:
Cost of services	608			526,198			90,475			—			617,281
General and administrative	17,696			44			—			—			17,740
Bad debt expense	—			7,563			1,699			—			9,262
Depreciation and amortization	917			12,831			2,415			—			16,163
Total costs and expenses	19,221			546,636			94,589			—			660,446
Income (loss) from operations	(19,209		)	70,779			10,829			—			62,399
Other income and expense:
Intercompany interest and royalty fees	(278		)	310			(32		)	—			—
Intercompany management fees	32,621			(27,386		)	(5,235		)	—			—
Equity in earnings (losses) of unconsolidated subsidiaries	—			(196		)	17			—			(179		)
Interest expense	(14,192		)	(6,031		)	(1,029		)	—			(21,252		)
Income (loss) from operations before income taxes	(1,058		)	37,476			4,550			—			40,968
Income tax expense	44			15,218			499			—			15,761
Equity in earnings of subsidiaries	24,374			1,952			—			(26,326		)(a)	—
Net income	23,272			24,210			4,051			(26,326		)	25,207
Less: Net income attributable to non-controlling interests	—			—			1,935			—			1,935
Net income attributable to Select Medical Corporation	$	23,272		$	24,210		$	2,116		$	(26,326	)	$	23,272
(a) Elimination of equity in earnings of subsidiaries.
Select Medical Corporation
Condensed Consolidating Statement of Operations
For the Nine Months Ended September 30, 2013
(unaudited)
	Select Medical			Subsidiary			Non-			Eliminations			Consolidated
	Corporation (Parent			Guarantors			Guarantor
	Company Only)						Subsidiaries
	(in thousands)
Net operating revenues	$	322		$	1,913,597		$	315,554		$	—		$	2,229,473
Costs and expenses:
Cost of services	1,718			1,599,493			266,704			—			1,867,915
General and administrative	52,915			150			—			—			53,065
Bad debt expense	—			22,485			4,944			—			27,429
Depreciation and amortization	2,862			37,856			7,154			—			47,872
Total costs and expenses	57,495			1,659,984			278,802			—			1,996,281
Income (loss) from operations	(57,173		)	253,613			36,752			—			233,192
Other income and expense:
Intercompany interest and royalty fees	(1,033		)	1,051			(18		)	—			—
Intercompany management fees	114,597			(100,005		)	(14,592		)	—			—
Loss on early retirement of debt	(17,788		)	—			—			—			(17,788		)
Equity in earnings of unconsolidated subsidiaries	—			1,375			72			—			1,447
Interest expense	(44,345		)	(16,800		)	(3,059		)	—			(64,204		)
Income (loss) from operations before income taxes	(5,742		)	139,234			19,155			—			152,647
Income tax expense	1,956			55,900			714						58,570
Equity in earnings of subsidiaries	95,358			12,073			—			(107,431		)(a)	—
Net income	87,660			95,407			18,441			(107,431		)	94,077
Less: Net income attributable to non-controlling interests	—			—			6,417			—			6,417
Net income attributable to Select Medical Corporation	$	87,660		$	95,407		$	12,024		$	(107,431	)	$	87,660
(a) Elimination of equity in earnings of subsidiaries.
Select Medical Corporation
Condensed Consolidating Statement of Cash Flows
For the Nine Months Ended September 30, 2013
(unaudited)
	Select Medical			Subsidiary			Non-			Eliminations			Consolidated
	Corporation			Guarantors			Guarantor
	(Parent Company						Subsidiaries
	Only)
	(in thousands)
Operating activities
Net income	$	87,660		$	95,407		$	18,441		$	(107,431	)(a)	$	94,077
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,862			37,856			7,154			—			47,872
Provision for bad debts	—			22,485			4,944			—			27,429
Equity in earnings of unconsolidated subsidiaries	—			(1,375		)	(72		)	—			(1,447		)
Loss on early retirement of debt	17,788			—			—			—			17,788
Loss (gain) from disposal of assets	—			25			(118		)	—			(93		)
Non-cash stock compensation expense	5,403			—			—			—			5,403
Amortization of debt discount and issuance costs	6,418			—			—			—			6,418
Changes in operating assets and liabilities, net of effects from acquisition of businesses:
Equity in earnings of subsidiaries	(95,358		)	(12,073		)	—			107,431		(a)	—
Accounts receivable	—			(75,295		)	(13,942		)	—			(89,237		)
Other current assets	(2,725		)	(6,620		)	1,703			—			(7,642		)
Other assets	(7,829		)	4,519			99			—			(3,211		)
Accounts payable	2,880			3,224			694			—			6,798
Due to third-party payors	—			2,378			512			—			2,890
Accrued expenses	(3,211		)	10,381			876			—			8,046
Income and deferred taxes	5,593			—			—			—			5,593
Net cash provided by operating activities	19,481			80,912			20,291			—			120,684
Investing activities
Purchases of property and equipment	(1,428		)	(39,101		)	(4,802		)	—			(45,331		)
Proceeds from sale of assets	—			62			456			—			518
Investment in businesses, net of distributions	—			(32,430		)	—			—			(32,430		)
Acquisition of businesses, net of cash acquired	—			(848		)	—			—			(848		)
Net cash used in investing activities	(1,428		)	(72,317		)	(4,346		)	—			(78,091		)
Financing activities
Borrowings on revolving credit facility	580,000			—			—			—			580,000
Payments on revolving credit facility	(645,000		)	—			—			—			(645,000		)
Borrowings on credit facility term loans, net of discount	298,500			—			—			—			298,500
Payments on credit facility term loans	(594,668		)	—			—			—			(594,668		)
Issuance of 6.375% senior notes	600,000			—			—			—			600,000
Repurchase of 7 5/8% senior subordinated notes	(70,000		)	—			—			—			(70,000		)
Borrowings of other debt	8,154			—			1,084			—			9,238
Principal payments on other debt	(5,971		)	(521		)	(975		)	—			(7,467		)
Debt issuance costs	(18,820		)	—			—			—			(18,820		)
Dividends paid to Holdings	(211,754		)	—			—			—			(211,754		)
Repayments of bank overdrafts	(10,401		)	—			—			—			(10,401		)
Intercompany	21,889			(8,812		)	(13,077		)	—			—
Distributions to non-controlling interests	—			—			(3,072		)	—			(3,072		)
Net cash used in financing activities	(48,071		)	(9,333		)	(16,040		)	—			(73,444		)
Net decrease in cash and cash equivalents	(30,018		)	(738		)	(95		)	—			(30,851		)
Cash and cash equivalents at beginning of period	35,070			3,734			1,340			—			40,144
Cash and cash equivalents at end of period	$	5,052		$	2,996		$	1,245		$	—		$	9,293
(a)  Elimination of equity in earnings of consolidated subsidiaries.
Select Medical Corporation
Consolidating Balance Sheet
December 31, 2012
(unaudited)
	Select Medical			Subsidiary			Non-Guarantor			Eliminations			Consolidated
	Corporation (Parent			Guarantors			Subsidiaries
	Company Only)
	(in thousands)
Assets
Current Assets:
Cash and cash equivalents	$	35,070		$	3,734		$	1,340		$	—		$	40,144
Accounts receivable, net	—			308,043			53,531			(1,645		)(a)	359,929
Current deferred tax asset	12,383			1,060			4,434			—			17,877
Prepaid income taxes	3,895			—			—			—			3,895
Intercompany receivables	—			1,021,479			102,694			(1,124,173		)(b)	—
Other current assets	5,600			19,655			6,563			—			31,818
Total Current Assets	56,948			1,353,971			168,562			(1,125,818		)	453,663
Property and equipment, net	16,344			425,677			59,531			—			501,552
Investment in affiliates	2,930,022			82,475			—			(3,012,497		)(c) (d)	—
Goodwill	—			1,640,534			—			—			1,640,534
Other identifiable intangibles	—			71,745			—			—			71,745
Non-current deferred tax asset	5,107			—			—			(5,107		)(e)	—
Other assets	28,680			63,447			692			—			92,819
Total Assets	$	3,037,101		$	3,637,849		$	228,785		$	(4,143,422	)	$	2,760,313
Liabilities and Equity
Current Liabilities:
Bank overdrafts	$	17,836		$	—		$	—		$	—		$	17,836
Current portion of long-term debt and notes payable	8,916			1,059			1,671			—			11,646
Accounts payable	4,674			72,213			12,660			—			89,547
Intercompany payables	1,124,173			—			—			(1,124,173		)(b)	—
Accrued payroll	186			88,096			304			—			88,586
Accrued vacation	4,249			44,508			6,957			—			55,714
Accrued interest	17,955			804			—			—			18,759
Accrued other	58,650			39,876			8,754			—			107,280
Due to third party payors	—			—			2,723			(1,645		)(a)	1,078
Total Current Liabilities	1,236,639			246,556			33,069			(1,125,818		)	390,446
Long-term debt, net of current portion	872,671			358,104			60,522			—			1,291,297
Non-current deferred tax liability	—			85,287			9,330			(5,107		)(e)	89,510
Other non-current liabilities	46,474			20,275			1,753			—			68,502
Total Liabilities	2,155,784			710,222			104,674			(1,130,925		)	1,839,755
Redeemable non-controlling interests	—			—			10,811			—			10,811
Stockholder’s Equity:
Common stock	0			—			—			—			0
Capital in excess of par	859,839			—			—			—			859,839
Retained earnings	21,478			790,692			21,197			(811,889		)(d)	21,478
Subsidiary investment	—			2,136,935			63,673			(2,200,608		)(c)	—
Total Select Medical Corporation Stockholder’s Equity	881,317			2,927,627			84,870			(3,012,497		)	881,317
Non-controlling interests	—			—			28,430			—			28,430
Total Equity	881,317			2,927,627			113,300			(3,012,497		)	909,747
Total Liabilities and Equity	$	3,037,101		$	3,637,849		$	228,785		$	(4,143,422	)	$	2,760,313
(a)  Reclass portion of due to third party payor to accounts receivable net in consolidation.
(b)  Elimination of intercompany.
(c)  Elimination of investments in consolidated subsidiaries.
(d)  Elimination of investments in consolidated subsidiaries’ earnings.
(e)  Reclass of non-current deferred tax asset to report net non-current deferred tax liability in consolidation.
Select Medical Corporation
Condensed Consolidating Statement of Operations
For the Three Months Ended September 30, 2012
(unaudited)
	Select Medical			Subsidiary			Non-			Eliminations			Consolidated
	Corporation (Parent			Guarantors			Guarantor
	Company Only)						Subsidiaries
	(in thousands)
Net operating revenues	$	14		$	616,610		$	97,045		$	—		$	713,669
Costs and expenses:
Cost of services	544			514,136			84,304			—			598,984
General and administrative	17,742			(612		)	—			—			17,130
Bad debt expense	—			9,525			1,674			—			11,199
Depreciation and amortization	832			12,372			2,333			—			15,537
Total costs and expenses	19,118			535,421			88,311			—			642,850
Income (loss) from operations	(19,104		)	81,189			8,734			—			70,819
Other income and expense:
Intercompany interest and royalty fees	(469		)	459			10			—			—
Intercompany management fees	34,811			(29,960		)	(4,851		)	—			—
Loss on early retirement of debt	(6,064		)	—			—			—			(6,064		)
Equity in earnings of unconsolidated subsidiaries	—			1,146			21			—			1,167
Interest expense	(14,676		)	(6,010		)	(1,054		)	—			(21,740		)
Income (loss) from operations before income taxes	(5,502		)	46,824			2,860			—			44,182
Income tax expense (benefit)	(3,589		)	21,020			(250		)	—			17,181
Equity in earnings of subsidiaries	27,866			2,123			—			(29,989		)(a)	—
Net income	25,953			27,927			3,110			(29,989		)	27,001
Less: Net income attributable to non-controlling interests	—			—			1,048			—			1,048
Net income attributable to Select Medical Corporation	$	25,953		$	27,927		$	2,062		$	(29,989	)	$	25,953
(a) Elimination of equity in earnings of subsidiaries.
Select Medical Corporation
Condensed Consolidating Statement of Operations
For the Nine Months Ended September 30, 2012
(unaudited)
	Select Medical			Subsidiary			Non-			Eliminations			Consolidated
	Corporation (Parent			Guarantors			Guarantor
	Company Only)						Subsidiaries
	(in thousands)
Net operating revenues	$	111		$	1,910,563		$	297,209		$	—		$	2,207,883
Costs and expenses:
Cost of services	1,554			1,567,080			254,638			—			1,823,272
General and administrative	51,197			(1,289		)	—			—			49,908
Bad debt expense	—			27,199			4,404			—			31,603
Depreciation and amortization	2,255			37,952			6,957			—			47,164
Total costs and expenses	55,006			1,630,942			265,999			—			1,951,947
Income (loss) from operations	(54,895		)	279,621			31,210			—			255,936
Other income and expense:
Intercompany interest and royalty fees	(2,025		)	1,998			27			—			—
Intercompany management fees	91,940			(78,202		)	(13,738		)	—			—
Loss on early retirement of debt	(6,064		)	—			—			—			(6,064		)
Equity in earnings of unconsolidated subsidiaries	—			6,340			44			—			6,384
Interest expense	(40,823		)	(19,920		)	(3,204		)	—			(63,947		)
Income (loss) from operations before income taxes	(11,867		)	189,837			14,339			—			192,309
Income tax expense (benefit)	(1,613		)	75,924			26			—			74,337
Equity in earnings of subsidiaries	124,504			11,234			—			(135,738		)(a)	—
Net income	114,250			125,147			14,313			(135,738		)	117,972
Less: Net income attributable to non-controlling interests	—			—			3,722			—			3,722
Net income attributable to Select Medical Corporation	$	114,250		$	125,147		$	10,591		$	(135,738	)	$	114,250
(a) Elimination of equity in earnings of subsidiaries.
Select Medical Corporation
Condensed Consolidating Statement of Cash Flows
For the Nine Months Ended September 30, 2012
(unaudited)
	Select Medical			Subsidiary			Non-			Eliminations			Consolidated
	Corporation (Parent			Guarantors			Guarantor
	Company Only)						Subsidiaries
	(in thousands)
Operating activities
Net income	$	114,250		$	125,147		$	14,313		$	(135,738	)(a)	$	117,972
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,255			37,952			6,957			—			47,164
Provision for bad debts	—			27,199			4,404			—			31,603
Equity in earnings of unconsolidated subsidiaries	—			(6,340		)	(44		)	—			(6,384		)
Loss on early retirement of debt	6,064			—			—			—			6,064
Loss (gain) from disposal of assets	—			(3,501		)	17			—			(3,484		)
Non-cash stock compensation expense	3,990			—			—			—			3,990
Amortization of debt discount and issuance costs	5,215			—			—			—			5,215
Changes in operating assets and liabilities, net of effects from acquisition of businesses:
Equity in earnings of subsidiaries	(124,504		)	(11,234		)	—			135,738		(a)	—
Accounts receivable	—			7,296			(17,803		)	—			(10,507		)
Other current assets	1,182			(2,141		)	(890		)	—			(1,849		)
Other assets	(604		)	1,688			186			—			1,270
Accounts payable	418			(5,842		)	1,326			—			(4,098		)
Due to third-party payors	—			(10,928		)	11,288			—			360
Accrued expenses	3,870			(1,912		)	998			—			2,956
Income and deferred taxes	14,481			—			—			—			14,481
Net cash provided by operating activities	26,617			157,384			20,752			—			204,753
Investing activities
Purchases of property and equipment	(3,617		)	(31,978		)	(9,593		)	—			(45,188		)
Proceeds from sale of assets	—			16,511			—			—			16,511
Investment in business, net of distributions	—			(9,899		)	—			—			(9,899		)
Acquisition of businesses, net of cash acquired	—			(1,547		)	—			—			(1,547		)
Net cash used in investing activities	(3,617		)	(26,913		)	(9,593		)	—			(40,123		)
Financing activities
Borrowings on revolving credit facility	365,000			—			—			—			365,000
Payments on revolving credit facility	(405,000		)	—			—			—			(405,000		)
Borrowings on credit facility term loans, net of discount	266,750			—			—			—			266,750
Payments on credit facility term loans	(7,063		)	—			—			—			(7,063		)
Repurchase of 7 5/8% senior subordinated notes	(278,495		)	—			—			—			(278,495		)
Borrowings of other debt	5,557			—			278			—			5,835
Principal payments on other debt	(6,667		)	(322		)	(428		)	—			(7,417		)
Debt issuance costs	(4,236		)	—			—			—			(4,236		)
Dividends paid to Holdings	(57,467		)	—			—			—			(57,467		)
Equity investment by Holdings	1,104			—			—			—			1,104
Repayment of bank overdrafts	(3,011		)	—			—			—			(3,011		)
Intercompany	134,170			(126,614		)	(7,556		)	—			—
Distributions to non-controlling interests	—			—			(2,997		)	—			(2,997		)
Net cash provided by (used in) financing activities	10,642			(126,936		)	(10,703		)	—			(126,997		)
Net increase in cash and cash equivalents	33,642			3,535			456			—			37,633
Cash and cash equivalents at beginning of period	11,427			—			616			—			12,043
Cash and cash equivalents at end of period	$	45,069		$	3,535		$	1,072		$	—		$	49,676
(a)  Elimination of equity in earnings of consolidated subsidiaries.

Accounting_Policies_Policies

Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2013
Accounting Policies	'
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.

Intangible_Assets_Tables

Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2013
Intangible Assets	'
Schedule of gross carrying amounts of the Company's indefinite-lived intangible assets	'
		December 31,		September 30,
		2012		2013
		(in thousands)
	Goodwill	$	1,640,534	$	1,641,836
	Trademarks	57,709		57,709
	Certificates of need	11,914		12,039
	Accreditations	2,122		2,083
	Total	$	1,712,279	$	1,713,667
Schedule of changes in the carrying amount of goodwill for the Company's reportable segments	'
		Specialty		Outpatient			Total
		Hospitals		Rehabilitation
		(in thousands)
	Balance as of December 31, 2012	$	1,333,220	$	307,314		$	1,640,534
	Goodwill acquired during the period	1,395		40			1,435
	Purchase price adjustment	—		(133		)	(133		)
	Balance as of September 30, 2013	$	1,334,615	$	307,221		$	1,641,836

Indebtedness_Tables

Indebtedness (Tables)	9 Months Ended
	Sep. 30, 2013
Indebtedness	'
Schedule of components of long-term debt and notes payable	'
		Select Medical Holdings Corporation
		December 31,		September 30,
		2012		2013
		(in thousands)
	7 5/8% senior subordinated notes	$	70,000	$	—
	6.375% senior notes	—		600,000
	Senior secured credit facilities:
	Revolving loan	130,000		65,000
	Term loans (1)	1,096,641		809,438
	Senior floating rate notes	167,300		—
	Other	6,302		14,443
	Total debt	1,470,243		1,488,881
	Less: current maturities	11,646		13,966
	Total long-term debt	$	1,458,597	$	1,474,915
		Select Medical Corporation
		December 31,		September 30,
		2012		2013
		(in thousands)
	7 5/8% senior subordinated notes	$	70,000	$	—
	6.375% senior notes	—		600,000
	Senior secured credit facilities:
	Revolving loan	130,000		65,000
	Term loans (1)	1,096,641		809,438
	Other	6,302		14,443
	Total debt	1,302,943		1,488,881
	Less: current maturities	11,646		13,966
	Total long-term debt	$	1,291,297	$	1,474,915
	(1)         Presented net of unamortized discounts of $14.2 million and $6.8 million at December 31, 2012 and September 30, 2013, respectively.
Schedule of maturities of the Company's long-term debt	'
	Maturities of the Company’s long-term debt for the period from October 1, 2013 through December 31, 2013 and the years after 2013 are approximately as follows and are presented net of the discounts on the senior secured credit facility term loans (in thousands):
	October 1, 2013 – December 31, 2013	$	4,869
	2014	11,497
	2015	10,086
	2016	296,134
	2017	4,075
	2018 and beyond	1,162,220

Segment_Information_Tables

Segment Information (Tables)	9 Months Ended
	Sep. 30, 2013
Segment Information	'
Schedule of selected financial data for the Company's reportable segments	'
		Three Months Ended September 30, 2012
		Specialty			Outpatient			Other			Total
		Hospitals			Rehabilitation
		(in thousands)
	Net operating revenues	$	531,409		$	182,246		$	14		$	713,669
	Adjusted EBITDA	83,659			20,354			(16,266		)	87,747
	Total assets:
	Select Medical Corporation	2,165,248			431,310			184,120			2,780,678
	Select Medical Holdings Corporation	2,165,248			431,310			185,250			2,781,808
	Capital expenditures	12,281			3,073			1,900			17,254
		Three Months Ended September 30, 2013
		Specialty			Outpatient			Other			Total
		Hospitals			Rehabilitation
		(in thousands)
	Net operating revenues	$	532,610		$	190,223		$	12		$	722,845
	Adjusted EBITDA	75,280			21,619			(16,471		)	80,428
	Total assets:
	Select Medical Corporation	2,232,756			445,729			163,939			2,842,424
	Select Medical Holdings Corporation	2,232,756			445,729			163,939			2,842,424
	Capital expenditures	14,157			2,802			410			17,369
		Nine Months Ended September 30, 2012
		Specialty			Outpatient			Other			Total
		Hospitals			Rehabilitation
		(in thousands)
	Net operating revenues	$	1,641,577		$	566,195		$	111		$	2,207,883
	Adjusted EBITDA	285,779			68,669			(47,358		)	307,090
	Total assets:
	Select Medical Corporation	2,165,248			431,310			184,120			2,780,678
	Select Medical Holdings Corporation	2,165,248			431,310			185,250			2,781,808
	Capital expenditures	31,963			9,786			3,439			45,188
		Nine Months Ended September 30, 2013
		Specialty			Outpatient			Other			Total
		Hospitals			Rehabilitation
		(in thousands)
	Net operating revenues	$	1,649,747		$	579,404		$	322		$	2,229,473
	Adjusted EBITDA	265,020			70,506			(49,059		)	286,467
	Total assets:
	Select Medical Corporation	2,232,756			445,729			163,939			2,842,424
	Select Medical Holdings Corporation	2,232,756			445,729			163,939			2,842,424
	Capital expenditures	35,257			8,646			1,428			45,331
Schedule of reconciliation of Adjusted EBITDA to income before income taxes	'
			Three Months Ended September 30, 2012
			Specialty					Outpatient			Other			Select			Select
			Hospitals					Rehabilitation						Medical			Medical
														Holdings			Corporation
														Corporation
			(in thousands)
	Adjusted EBITDA		$			83,659		$	20,354		$	(16,266	)
	Depreciation and amortization		(11,553				)	(3,152		)	(832		)
	Stock compensation expense		—					—			(1,391		)
	Income (loss) from operations		$		72,106			$	17,202		$	(18,489	)	$	70,819		$	70,819
	Loss on early retirement of debt													(6,064		)	(6,064		)
	Equity in earnings of unconsolidated subsidiaries													1,167			1,167
	Interest expense													(24,575		)	(21,740		)
	Income before income taxes													$	41,347		$	44,182
		Three Months Ended September 30, 2013
		Specialty			Outpatient			Other			Select			Select
		Hospitals			Rehabilitation						Medical			Medical
											Holdings			Corporation
											Corporation
		(in thousands)
	Adjusted EBITDA	$	75,280		$	21,619		$	(16,471	)
	Depreciation and amortization	(12,267		)	(2,979		)	(917		)
	Stock compensation expense	—			—			(1,866		)
	Income (loss) from operations	$	63,013		$	18,640		$	(19,254	)	$	62,399		$	62,399
	Equity in losses of unconsolidated subsidiaries										(179		)	(179		)
	Interest expense										(21,252		)	(21,252		)
	Income before income taxes										$	40,968		$	40,968
				Nine Months Ended September 30, 2012
				Specialty				Outpatient			Other			Select			Select
				Hospitals				Rehabilitation						Medical			Medical
														Holdings			Corporation
														Corporation
				(in thousands)
	Adjusted EBITDA			$		285,779		$	68,669		$	(47,358	)
	Depreciation and amortization					(34,875	)		(10,034	)		(2,255	)
	Stock compensation expense			—				—			(3,990		)
	Income (loss) from operations		$			250,904		$	58,635		$	(53,603	)	$	255,936		$	255,936
	Loss on early retirement of debt													(6,064		)	(6,064		)
	Equity in earnings of unconsolidated subsidiaries													6,384			6,384
	Interest expense													(72,295		)	(63,947		)
	Income before income taxes													$	183,961		$	192,309
		Nine Months Ended September 30, 2013
		Specialty			Outpatient			Other			Select			Select
		Hospitals			Rehabilitation						Medical			Medical
											Holdings			Corporation
											Corporation
		(in thousands)
	Adjusted EBITDA	$	265,020		$	70,506		$	(49,059	)
	Depreciation and amortization	(36,061		)	(8,949		)	(2,862		)
	Stock compensation expense	—			—			(5,403		)
	Income (loss) from operations	$	228,959		$	61,557		$	(57,324	)	$	233,192		$	233,192
	Equity in earnings of unconsolidated subsidiaries										1,447			1,447
	Loss on early retirement of debt										(18,747		)	(17,788		)
	Interest expense										(66,614		)	(64,204		)
	Income before income taxes										$	149,278		$	152,647

Income_per_Common_Share_Tables

Income per Common Share (Tables)	9 Months Ended
	Sep. 30, 2013
Income per Common Share	'
Schedule of computation of basic and diluted income per common share	'
		For the Three Months					For the Nine Months
		Ended September 30,					Ended September 30,
		2012			2013		2012		2013
		(in thousands, except per share amounts)
	Numerator:
	Net income attributable to Select Medical Holdings Corporation	$	24,110		$	23,272	$	108,824	$	85,470
	Less: Earnings allocated to unvested restricted stockholders	407			497		1,759		1,802
	Net income available to common stockholders	$	23,703		$	22,775	$	107,065	$	83,668
	Denominator:
	Weighted average shares — basic	137,551			136,646		139,138		136,879
	Effect of dilutive securities:
	Stock options	337			147		266		161
	Weighted average shares — diluted	137,888			136,793		139,404		137,040
	Basic income per common share	$	0.17		$	0.17	$	0.77	$	0.61
	Diluted income per common share	$	0.17		$	0.17	$	0.77	$	0.61
Schedule of anti-dilutive shares excluded from computation	'
		For the Three Months				For the Nine Months
		Ended September 30,				Ended September 30,
		2012		2013		2012	2013
		(in thousands)
	Stock options	78		1,477		1,683	1,528

Financial_Information_for_Subs1

Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 6.375% Senior Notes (Tables)	9 Months Ended
	Sep. 30, 2013
Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 6.375% Senior Notes	'
Schedule of Consolidating Balance Sheet	'
	Condensed Consolidating Balance Sheet
	September 30, 2013
	(unaudited)
		Select Medical			Subsidiary			Non-Guarantor			Eliminations			Consolidated
		Corporation (Parent			Guarantors			Subsidiaries
		Company Only)
		(in thousands)
	Assets
	Current Assets:
	Cash and cash equivalents	$	5,052		$	2,996		$	1,245		$	—		$	9,293
	Accounts receivable, net	—			360,805			62,529			—			423,334
	Current deferred tax asset	8,038			2,945			4,389			—			15,372
	Prepaid income taxes	4,044			—			—			—			4,044
	Intercompany receivables	—			1,034,542			100,930			(1,135,472		)(a)	—
	Other current assets	8,325			26,783			4,860			—			39,968
	Total Current Assets	25,459			1,428,071			173,953			(1,135,472		)	492,011
	Property and equipment, net	14,911			426,915			57,705			—			499,531
	Investment in affiliates	3,024,968			80,282			—			(3,105,250		)(b) (c)	—
	Goodwill	—			1,641,836			—			—			1,641,836
	Other identifiable intangibles	—			71,831			—			—			71,831
	Non-current deferred tax asset	8,097			—			—			(8,097		)(d)	—
	Other assets	36,509			100,113			593			—			137,215
	Total Assets	$	3,109,944		$	3,749,048		$	232,251		$	(4,248,819	)	$	2,842,424
	Liabilities and Equity
	Current Liabilities:
	Bank overdrafts	$	7,435		$	—		$	—		$	—		$	7,435
	Current portion of long-term debt and notes payable	9,467			1,918			2,581			—			13,966
	Accounts payable	7,554			75,452			13,354			—			96,360
	Intercompany payables	1,135,472			—			—			(1,135,472		)(a)	—
	Accrued payroll	516			80,527			260			—			81,303
	Accrued vacation	4,502			45,567			7,259			—			57,328
	Accrued interest	20,783			1,222			—			—			22,005
	Accrued other	52,028			41,525			9,372			—			102,925
	Due to third party payors	—			733			3,235			—			3,968
	Total Current Liabilities	1,237,757			246,944			36,061			(1,135,472		)	385,290
	Long-term debt, net of current portion	1,048,053			367,232			59,630			—			1,474,915
	Non-current deferred tax liability	—			89,222			9,734			(8,097		)(d)	90,859
	Other non-current liabilities	55,718			23,028			1,331			—			80,077
	Total Liabilities	2,341,528			726,426			106,756			(1,143,569		)	2,031,141
	Redeemable non-controlling interest	—			—			11,623			—			11,623
	Stockholder’s Equity:
	Common stock	0			—			—			—			0
	Capital in excess of par	866,423			—			—			—			866,423
	Retained earnings (accumulated deficit)	(98,007		)	886,099			18,438			(904,537		)(c)	(98,007		)
	Subsidiary investment	—			2,136,523			64,190			(2,200,713		)(b)	—
	Total Select Medical Corporation Stockholder’s Equity	768,416			3,022,622			82,628			(3,105,250		)	768,416
	Non-controlling interest	—			—			31,244			—			31,244
	Total Equity	768,416			3,022,622			113,872			(3,105,250		)	799,660
	Total Liabilities and Equity	$	3,109,944		$	3,749,048		$	232,251		$	(4,248,819	)	$	2,842,424
	(a)  Elimination of intercompany.
	(b)  Elimination of investments in consolidated subsidiaries.
	(c)  Elimination of investments in consolidated subsidiaries’ earnings.
	(d)  Reclass of non-current deferred tax asset to report net non-current deferred tax liability in consolidation.
	Consolidating Balance Sheet
	December 31, 2012
	(unaudited)
		Select Medical			Subsidiary			Non-Guarantor			Eliminations			Consolidated
		Corporation (Parent			Guarantors			Subsidiaries
		Company Only)
		(in thousands)
	Assets
	Current Assets:
	Cash and cash equivalents	$	35,070		$	3,734		$	1,340		$	—		$	40,144
Accounts receivable, net	—			308,043			53,531			(1,645		)(a)	359,929
Current deferred tax asset	12,383			1,060			4,434			—			17,877
Prepaid income taxes	3,895			—			—			—			3,895
Intercompany receivables	—			1,021,479			102,694			(1,124,173		)(b)	—
Other current assets	5,600			19,655			6,563			—			31,818
Total Current Assets	56,948			1,353,971			168,562			(1,125,818		)	453,663
Property and equipment, net	16,344			425,677			59,531			—			501,552
Investment in affiliates	2,930,022			82,475			—			(3,012,497		)(c) (d)	—
Goodwill	—			1,640,534			—			—			1,640,534
Other identifiable intangibles	—			71,745			—			—			71,745
Non-current deferred tax asset	5,107			—			—			(5,107		)(e)	—
Other assets	28,680			63,447			692			—			92,819
Total Assets	$	3,037,101		$	3,637,849		$	228,785		$	(4,143,422	)	$	2,760,313
Liabilities and Equity
Current Liabilities:
Bank overdrafts	$	17,836		$	—		$	—		$	—		$	17,836
Current portion of long-term debt and notes payable	8,916			1,059			1,671			—			11,646
Accounts payable	4,674			72,213			12,660			—			89,547
Intercompany payables	1,124,173			—			—			(1,124,173		)(b)	—
Accrued payroll	186			88,096			304			—			88,586
Accrued vacation	4,249			44,508			6,957			—			55,714
Accrued interest	17,955			804			—			—			18,759
Accrued other	58,650			39,876			8,754			—			107,280
Due to third party payors	—			—			2,723			(1,645		)(a)	1,078
Total Current Liabilities	1,236,639			246,556			33,069			(1,125,818		)	390,446
Long-term debt, net of current portion	872,671			358,104			60,522			—			1,291,297
Non-current deferred tax liability	—			85,287			9,330			(5,107		)(e)	89,510
Other non-current liabilities	46,474			20,275			1,753			—			68,502
Total Liabilities	2,155,784			710,222			104,674			(1,130,925		)	1,839,755
Redeemable non-controlling interests	—			—			10,811			—			10,811
Stockholder’s Equity:
Common stock	0			—			—			—			0
Capital in excess of par	859,839			—			—			—			859,839
Retained earnings	21,478			790,692			21,197			(811,889		)(d)	21,478
Subsidiary investment	—			2,136,935			63,673			(2,200,608		)(c)	—
Total Select Medical Corporation Stockholder’s Equity	881,317			2,927,627			84,870			(3,012,497		)	881,317
Non-controlling interests	—			—			28,430			—			28,430
Total Equity	881,317			2,927,627			113,300			(3,012,497		)	909,747
Total Liabilities and Equity	$	3,037,101		$	3,637,849		$	228,785		$	(4,143,422	)	$	2,760,313
(a)  Reclass portion of due to third party payor to accounts receivable net in consolidation.
(b)  Elimination of intercompany.
(c)  Elimination of investments in consolidated subsidiaries.
(d)  Elimination of investments in consolidated subsidiaries’ earnings.
(e)  Reclass of non-current deferred tax asset to report net non-current deferred tax liability in consolidation.
Schedule of Consolidating Statement of Operations	'
	Condensed Consolidating Statement of Operations
	For the Three Months Ended September 30, 2013
	(unaudited)
		Select Medical			Subsidiary			Non-			Eliminations			Consolidated
		Corporation (Parent			Guarantors			Guarantor
		Company Only)						Subsidiaries
		(in thousands)
	Net operating revenues	$	12		$	617,415		$	105,418		$	—		$	722,845
	Costs and expenses:
	Cost of services	608			526,198			90,475			—			617,281
	General and administrative	17,696			44			—			—			17,740
	Bad debt expense	—			7,563			1,699			—			9,262
	Depreciation and amortization	917			12,831			2,415			—			16,163
	Total costs and expenses	19,221			546,636			94,589			—			660,446
	Income (loss) from operations	(19,209		)	70,779			10,829			—			62,399
	Other income and expense:
	Intercompany interest and royalty fees	(278		)	310			(32		)	—			—
	Intercompany management fees	32,621			(27,386		)	(5,235		)	—			—
	Equity in earnings (losses) of unconsolidated subsidiaries	—			(196		)	17			—			(179		)
	Interest expense	(14,192		)	(6,031		)	(1,029		)	—			(21,252		)
	Income (loss) from operations before income taxes	(1,058		)	37,476			4,550			—			40,968
	Income tax expense	44			15,218			499			—			15,761
	Equity in earnings of subsidiaries	24,374			1,952			—			(26,326		)(a)	—
	Net income	23,272			24,210			4,051			(26,326		)	25,207
	Less: Net income attributable to non-controlling interests	—			—			1,935			—			1,935
	Net income attributable to Select Medical Corporation	$	23,272		$	24,210		$	2,116		$	(26,326	)	$	23,272
	(a) Elimination of equity in earnings of subsidiaries.
	Condensed Consolidating Statement of Operations
	For the Nine Months Ended September 30, 2013
	(unaudited)
		Select Medical			Subsidiary			Non-			Eliminations			Consolidated
		Corporation (Parent			Guarantors			Guarantor
		Company Only)						Subsidiaries
		(in thousands)
	Net operating revenues	$	322		$	1,913,597		$	315,554		$	—		$	2,229,473
	Costs and expenses:
	Cost of services	1,718			1,599,493			266,704			—			1,867,915
	General and administrative	52,915			150			—			—			53,065
	Bad debt expense	—			22,485			4,944			—			27,429
	Depreciation and amortization	2,862			37,856			7,154			—			47,872
	Total costs and expenses	57,495			1,659,984			278,802			—			1,996,281
	Income (loss) from operations	(57,173		)	253,613			36,752			—			233,192
	Other income and expense:
	Intercompany interest and royalty fees	(1,033		)	1,051			(18		)	—			—
	Intercompany management fees	114,597			(100,005		)	(14,592		)	—			—
	Loss on early retirement of debt	(17,788		)	—			—			—			(17,788		)
	Equity in earnings of unconsolidated subsidiaries	—			1,375			72			—			1,447
	Interest expense	(44,345		)	(16,800		)	(3,059		)	—			(64,204		)
	Income (loss) from operations before income taxes	(5,742		)	139,234			19,155			—			152,647
	Income tax expense	1,956			55,900			714						58,570
	Equity in earnings of subsidiaries	95,358			12,073			—			(107,431		)(a)	—
	Net income	87,660			95,407			18,441			(107,431		)	94,077
	Less: Net income attributable to non-controlling interests	—			—			6,417			—			6,417
	Net income attributable to Select Medical Corporation	$	87,660		$	95,407		$	12,024		$	(107,431	)	$	87,660
	(a) Elimination of equity in earnings of subsidiaries.
	Condensed Consolidating Statement of Operations
	For the Three Months Ended September 30, 2012
	(unaudited)
		Select Medical			Subsidiary			Non-			Eliminations			Consolidated
		Corporation (Parent			Guarantors			Guarantor
		Company Only)						Subsidiaries
		(in thousands)
	Net operating revenues	$	14		$	616,610		$	97,045		$	—		$	713,669
Costs and expenses:
Cost of services	544			514,136			84,304			—			598,984
General and administrative	17,742			(612		)	—			—			17,130
Bad debt expense	—			9,525			1,674			—			11,199
Depreciation and amortization	832			12,372			2,333			—			15,537
Total costs and expenses	19,118			535,421			88,311			—			642,850
Income (loss) from operations	(19,104		)	81,189			8,734			—			70,819
Other income and expense:
Intercompany interest and royalty fees	(469		)	459			10			—			—
Intercompany management fees	34,811			(29,960		)	(4,851		)	—			—
Loss on early retirement of debt	(6,064		)	—			—			—			(6,064		)
Equity in earnings of unconsolidated subsidiaries	—			1,146			21			—			1,167
Interest expense	(14,676		)	(6,010		)	(1,054		)	—			(21,740		)
Income (loss) from operations before income taxes	(5,502		)	46,824			2,860			—			44,182
Income tax expense (benefit)	(3,589		)	21,020			(250		)	—			17,181
Equity in earnings of subsidiaries	27,866			2,123			—			(29,989		)(a)	—
Net income	25,953			27,927			3,110			(29,989		)	27,001
Less: Net income attributable to non-controlling interests	—			—			1,048			—			1,048
Net income attributable to Select Medical Corporation	$	25,953		$	27,927		$	2,062		$	(29,989	)	$	25,953
(a) Elimination of equity in earnings of subsidiaries.
Condensed Consolidating Statement of Operations
For the Nine Months Ended September 30, 2012
(unaudited)
	Select Medical			Subsidiary			Non-			Eliminations			Consolidated
	Corporation (Parent			Guarantors			Guarantor
	Company Only)						Subsidiaries
	(in thousands)
Net operating revenues	$	111		$	1,910,563		$	297,209		$	—		$	2,207,883
Costs and expenses:
Cost of services	1,554			1,567,080			254,638			—			1,823,272
General and administrative	51,197			(1,289		)	—			—			49,908
Bad debt expense	—			27,199			4,404			—			31,603
Depreciation and amortization	2,255			37,952			6,957			—			47,164
Total costs and expenses	55,006			1,630,942			265,999			—			1,951,947
Income (loss) from operations	(54,895		)	279,621			31,210			—			255,936
Other income and expense:
Intercompany interest and royalty fees	(2,025		)	1,998			27			—			—
Intercompany management fees	91,940			(78,202		)	(13,738		)	—			—
Loss on early retirement of debt	(6,064		)	—			—			—			(6,064		)
Equity in earnings of unconsolidated subsidiaries	—			6,340			44			—			6,384
Interest expense	(40,823		)	(19,920		)	(3,204		)	—			(63,947		)
Income (loss) from operations before income taxes	(11,867		)	189,837			14,339			—			192,309
Income tax expense (benefit)	(1,613		)	75,924			26			—			74,337
Equity in earnings of subsidiaries	124,504			11,234			—			(135,738		)(a)	—
Net income	114,250			125,147			14,313			(135,738		)	117,972
Less: Net income attributable to non-controlling interests	—			—			3,722			—			3,722
Net income attributable to Select Medical Corporation	$	114,250		$	125,147		$	10,591		$	(135,738	)	$	114,250
(a) Elimination of equity in earnings of subsidiaries.
Schedule of Consolidating Statement of Cash Flows	'
	Condensed Consolidating Statement of Cash Flows
	For the Nine Months Ended September 30, 2013
	(unaudited)
		Select Medical			Subsidiary			Non-			Eliminations			Consolidated
		Corporation			Guarantors			Guarantor
		(Parent Company						Subsidiaries
		Only)
		(in thousands)
	Operating activities
	Net income	$	87,660		$	95,407		$	18,441		$	(107,431	)(a)	$	94,077
	Adjustments to reconcile net income to net cash provided by operating activities:
	Depreciation and amortization	2,862			37,856			7,154			—			47,872
	Provision for bad debts	—			22,485			4,944			—			27,429
	Equity in earnings of unconsolidated subsidiaries	—			(1,375		)	(72		)	—			(1,447		)
	Loss on early retirement of debt	17,788			—			—			—			17,788
	Loss (gain) from disposal of assets	—			25			(118		)	—			(93		)
	Non-cash stock compensation expense	5,403			—			—			—			5,403
	Amortization of debt discount and issuance costs	6,418			—			—			—			6,418
	Changes in operating assets and liabilities, net of effects from acquisition of businesses:
	Equity in earnings of subsidiaries	(95,358		)	(12,073		)	—			107,431		(a)	—
	Accounts receivable	—			(75,295		)	(13,942		)	—			(89,237		)
	Other current assets	(2,725		)	(6,620		)	1,703			—			(7,642		)
	Other assets	(7,829		)	4,519			99			—			(3,211		)
	Accounts payable	2,880			3,224			694			—			6,798
	Due to third-party payors	—			2,378			512			—			2,890
	Accrued expenses	(3,211		)	10,381			876			—			8,046
	Income and deferred taxes	5,593			—			—			—			5,593
	Net cash provided by operating activities	19,481			80,912			20,291			—			120,684
	Investing activities
	Purchases of property and equipment	(1,428		)	(39,101		)	(4,802		)	—			(45,331		)
	Proceeds from sale of assets	—			62			456			—			518
	Investment in businesses, net of distributions	—			(32,430		)	—			—			(32,430		)
	Acquisition of businesses, net of cash acquired	—			(848		)	—			—			(848		)
	Net cash used in investing activities	(1,428		)	(72,317		)	(4,346		)	—			(78,091		)
	Financing activities
	Borrowings on revolving credit facility	580,000			—			—			—			580,000
	Payments on revolving credit facility	(645,000		)	—			—			—			(645,000		)
	Borrowings on credit facility term loans, net of discount	298,500			—			—			—			298,500
	Payments on credit facility term loans	(594,668		)	—			—			—			(594,668		)
	Issuance of 6.375% senior notes	600,000			—			—			—			600,000
	Repurchase of 7 5/8% senior subordinated notes	(70,000		)	—			—			—			(70,000		)
	Borrowings of other debt	8,154			—			1,084			—			9,238
	Principal payments on other debt	(5,971		)	(521		)	(975		)	—			(7,467		)
	Debt issuance costs	(18,820		)	—			—			—			(18,820		)
	Dividends paid to Holdings	(211,754		)	—			—			—			(211,754		)
	Repayments of bank overdrafts	(10,401		)	—			—			—			(10,401		)
	Intercompany	21,889			(8,812		)	(13,077		)	—			—
	Distributions to non-controlling interests	—			—			(3,072		)	—			(3,072		)
	Net cash used in financing activities	(48,071		)	(9,333		)	(16,040		)	—			(73,444		)
	Net decrease in cash and cash equivalents	(30,018		)	(738		)	(95		)	—			(30,851		)
	Cash and cash equivalents at beginning of period	35,070			3,734			1,340			—			40,144
	Cash and cash equivalents at end of period	$	5,052		$	2,996		$	1,245		$	—		$	9,293
	(a)  Elimination of equity in earnings of consolidated subsidiaries.
	Condensed Consolidating Statement of Cash Flows
	For the Nine Months Ended September 30, 2012
	(unaudited)
		Select Medical			Subsidiary			Non-			Eliminations			Consolidated
		Corporation (Parent			Guarantors			Guarantor
		Company Only)						Subsidiaries
		(in thousands)
	Operating activities
	Net income	$	114,250		$	125,147		$	14,313		$	(135,738	)(a)	$	117,972
	Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,255			37,952			6,957			—			47,164
Provision for bad debts	—			27,199			4,404			—			31,603
Equity in earnings of unconsolidated subsidiaries	—			(6,340		)	(44		)	—			(6,384		)
Loss on early retirement of debt	6,064			—			—			—			6,064
Loss (gain) from disposal of assets	—			(3,501		)	17			—			(3,484		)
Non-cash stock compensation expense	3,990			—			—			—			3,990
Amortization of debt discount and issuance costs	5,215			—			—			—			5,215
Changes in operating assets and liabilities, net of effects from acquisition of businesses:
Equity in earnings of subsidiaries	(124,504		)	(11,234		)	—			135,738		(a)	—
Accounts receivable	—			7,296			(17,803		)	—			(10,507		)
Other current assets	1,182			(2,141		)	(890		)	—			(1,849		)
Other assets	(604		)	1,688			186			—			1,270
Accounts payable	418			(5,842		)	1,326			—			(4,098		)
Due to third-party payors	—			(10,928		)	11,288			—			360
Accrued expenses	3,870			(1,912		)	998			—			2,956
Income and deferred taxes	14,481			—			—			—			14,481
Net cash provided by operating activities	26,617			157,384			20,752			—			204,753
Investing activities
Purchases of property and equipment	(3,617		)	(31,978		)	(9,593		)	—			(45,188		)
Proceeds from sale of assets	—			16,511			—			—			16,511
Investment in business, net of distributions	—			(9,899		)	—			—			(9,899		)
Acquisition of businesses, net of cash acquired	—			(1,547		)	—			—			(1,547		)
Net cash used in investing activities	(3,617		)	(26,913		)	(9,593		)	—			(40,123		)
Financing activities
Borrowings on revolving credit facility	365,000			—			—			—			365,000
Payments on revolving credit facility	(405,000		)	—			—			—			(405,000		)
Borrowings on credit facility term loans, net of discount	266,750			—			—			—			266,750
Payments on credit facility term loans	(7,063		)	—			—			—			(7,063		)
Repurchase of 7 5/8% senior subordinated notes	(278,495		)	—			—			—			(278,495		)
Borrowings of other debt	5,557			—			278			—			5,835
Principal payments on other debt	(6,667		)	(322		)	(428		)	—			(7,417		)
Debt issuance costs	(4,236		)	—			—			—			(4,236		)
Dividends paid to Holdings	(57,467		)	—			—			—			(57,467		)
Equity investment by Holdings	1,104			—			—			—			1,104
Repayment of bank overdrafts	(3,011		)	—			—			—			(3,011		)
Intercompany	134,170			(126,614		)	(7,556		)	—			—
Distributions to non-controlling interests	—			—			(2,997		)	—			(2,997		)
Net cash provided by (used in) financing activities	10,642			(126,936		)	(10,703		)	—			(126,997		)
Net increase in cash and cash equivalents	33,642			3,535			456			—			37,633
Cash and cash equivalents at beginning of period	11,427			—			616			—			12,043
Cash and cash equivalents at end of period	$	45,069		$	3,535		$	1,072		$	—		$	49,676
(a)  Elimination of equity in earnings of consolidated subsidiaries.

Intangible_Assets_Details

Intangible Assets (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Indefinite-lived intangible assets:	'	'
Gross Carrying Amount of Goodwill	$1,641,836	$1,640,534
Gross Carrying Amount	1,713,667	1,712,279
Trademarks	'	'
Indefinite-lived intangible assets:	'	'
Gross Carrying Amount	57,709	57,709
Weighted average time until next renewal	'6 years 8 months 12 days	'
Certificates of need	'	'
Indefinite-lived intangible assets:	'	'
Gross Carrying Amount	12,039	11,914
Accreditations	'	'
Indefinite-lived intangible assets:	'	'
Gross Carrying Amount	$2,083	$2,122
Weighted average time until next renewal	'1 year 6 months	'

Intangible_Assets_Details_2

Intangible Assets (Details 2) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013
Goodwill.	'
Balance at the beginning of the period	$1,640,534
Goodwill acquired during the period	1,435
Purchase price adjustment	-133
Balance at the end of the period	1,641,836
Specialty Hospitals	'
Goodwill.	'
Balance at the beginning of the period	1,333,220
Goodwill acquired during the period	1,395
Balance at the end of the period	1,334,615
Outpatient Rehabilitation	'
Goodwill.	'
Balance at the beginning of the period	307,314
Goodwill acquired during the period	40
Purchase price adjustment	-133
Balance at the end of the period	$307,221

Indebtedness_Details

Indebtedness (Details) (USD $)

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

9 Months Ended

0 Months Ended

0 Months Ended

3 Months Ended

3 Months Ended

9 Months Ended

9 Months Ended

Mar. 31, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Dec. 31, 2012

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Dec. 31, 2012

Jun. 04, 2013

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Dec. 31, 2012

Jun. 30, 2013

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Feb. 20, 2013

Sep. 30, 2013

Sep. 30, 2013

Jun. 04, 2013

Jun. 01, 2011

Jun. 02, 2013

Jun. 02, 2013

Jun. 02, 2013

Aug. 13, 2012

Jun. 02, 2013

Jun. 02, 2013

Jun. 02, 2013

Jun. 04, 2013

Jun. 04, 2013

Jun. 04, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Dec. 31, 2012

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2013

Sep. 30, 2013

28-May-13

Sep. 30, 2013

Sep. 30, 2013

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Amended senior secured facilities

2011 - senior secured credit facilities: Revolving loan

2011 - senior secured credit facilities: Revolving loan

2011 - senior secured credit facilities: Revolving loan

2011 - senior secured credit facilities: Revolving loan

Senior secured credit facility

2011 - senior secured credit facilities: Term loans

2011 - senior secured credit facilities: Term loans

2011 - senior secured credit facilities: Term loans

2011 - senior secured credit facilities: Term loans

Series B Term Loan

Series B Term Loan

Series B Term Loan

Series B Term Loan

Series B Term Loan

Original term loan

Original term loan

Original term loan

Original term loan

Incremental term loan tranche

Incremental term loan tranche

Incremental term loan tranche

Incremental term loan tranche

Series C Term Loan

Series C Term Loan

Series C Term Loan

Senior floating rate notes

Senior floating rate notes

Other

Other

Other

Other

7 5/8% senior subordinated notes

7 5/8% senior subordinated notes

7 5/8% senior subordinated notes

7 5/8% senior subordinated notes

6.375% senior notes

6.375% senior notes

6.375% senior notes

6.375% senior notes

6.375% senior notes

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Amended senior secured facilities

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Amended senior secured facilities

Amended senior secured facilities

Amended senior secured facilities

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Maximum

Adjusted LIBO

Alternate base rate

Select Medical Corporation

Adjusted LIBO

Alternate base rate

Minimum

Adjusted LIBO

Alternate base rate

Minimum

Select Medical Corporation

Select Medical Corporation

Select Medical Corporation

Prior to June 1, 2016

Maximum

Adjusted LIBO

Adjusted LIBO

Adjusted LIBO

Alternate base rate

Minimum

Prior to June 1, 2016

Adjusted LIBO

Long-Term Debt and Notes Payable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest rate of debt (as a percent)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

7.63%

7.63%

'

7.63%

6.38%

6.38%

'

'

'

Total debt

'

'

$1,488,881,000

'

$1,470,243,000

'

$1,488,881,000

'

$1,302,943,000

'

$65,000,000

$130,000,000

$65,000,000

$130,000,000

'

$809,438,000

$1,096,641,000

$809,438,000

$1,096,641,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$167,300,000

$14,443,000

$6,302,000

$14,443,000

$6,302,000

'

$70,000,000

'

$70,000,000

$600,000,000

$600,000,000

'

'

'

Less: current maturities

'

'

13,966,000

'

11,646,000

'

13,966,000

'

11,646,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total long-term debt

'

'

1,474,915,000

'

1,458,597,000

'

1,474,915,000

'

1,291,297,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unamortized discounts

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6,800,000

14,200,000

6,800,000

14,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum borrowing capacity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

300,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Extended maturity amount of revolving credit facility

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

293,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Variable rate basis

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'Adjusted LIBO

'Alternate base rate

'

'

'Adjusted LIBO

'Alternate Base Rate

'

'

'Adjusted LIBO

'Alternate Base Rate

'

'Adjusted LIBO

'Alternate Base Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest rate margin (as a percent)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.25%

2.25%

'

'

3.75%

2.75%

'

'

3.75%

2.75%

'

3.00%

2.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Reference rate (as a percent)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.75%

'

'

'

1.75%

'

'

1.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Pro forma ratio of total indebtedness to Consolidated EBITDA

'

'

'

'

'

'

'

'

'

2.75

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Aggregate principal amount drawn

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

850,000,000

'

'

'

275,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

600,000,000

'

'

Loss on early retirement of debt

1,500,000

6,064,000

18,747,000

6,064,000

'

6,064,000

17,788,000

6,064,000

'

'

'

'

'

'

17,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,000,000

'

'

'

'

'

'

'

500,000

'

'

'

'

'

'

Periodic payment in equal quarterly installments

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of principal amount at which notes may be required to be repurchased in event of change of control by the entity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

101.00%

'

'

'

Percentage of the principal amount of the debt instrument which the entity may redeem with the proceeds from certain equity offerings

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

35.00%

Percentage of the principal amount representing the redemption price of notes which may be redeemed with proceeds from certain equity offerings

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

106.38%

'

Maturities of Long-Term Debt and Notes Payable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

October 1, 2013 - December 31, 2013

'

'

4,869,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2014

'

'

11,497,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2015

'

'

10,086,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2016

'

'

296,134,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2017

'

'

4,075,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2018 and beyond

'

'

$1,162,220,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair_Value_Details

Fair Value (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Fair Value	'	'
Carrying value	$1,488,881,000	$1,470,243,000
Select	'	'
Fair Value	'	'
Carrying value	1,488,881,000	1,302,943,000
Senior secured credit facility | Select	'	'
Fair Value	'	'
Carrying value	874,400,000	1,226,600,000
Fair value	867,900,000	1,216,200,000
6.375% senior notes	'	'
Fair Value	'	'
Carrying value	600,000,000	'
Interest rate of debt (as a percent)	6.38%	'
6.375% senior notes | Select	'	'
Fair Value	'	'
Carrying value	600,000,000	'
Fair value	$570,000,000	'
Interest rate of debt (as a percent)	6.38%	'

Segment_Information_Details

Segment Information (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Summary of selected financial data	'	'	'	'	'
Net operating revenues	$722,845	$713,669	$2,229,473	$2,207,883	'
Adjusted EBITDA	80,428	87,747	286,467	307,090	'
Total assets:	2,842,424	2,781,808	2,842,424	2,781,808	2,761,361
Capital expenditures	17,369	17,254	45,331	45,188	'
Select Medical Corporation	'	'	'	'	'
Summary of selected financial data	'	'	'	'	'
Net operating revenues	722,845	713,669	2,229,473	2,207,883	'
Total assets:	2,842,424	2,780,678	2,842,424	2,780,678	2,760,313
Capital expenditures	'	'	45,331	45,188	'
Operating Segments | Specialty Hospitals	'	'	'	'	'
Summary of selected financial data	'	'	'	'	'
Net operating revenues	532,610	531,409	1,649,747	1,641,577	'
Adjusted EBITDA	75,280	83,659	265,020	285,779	'
Total assets:	2,232,756	2,165,248	2,232,756	2,165,248	'
Capital expenditures	14,157	12,281	35,257	31,963	'
Operating Segments | Specialty Hospitals | Select Medical Corporation	'	'	'	'	'
Summary of selected financial data	'	'	'	'	'
Total assets:	2,232,756	2,165,248	2,232,756	2,165,248	'
Operating Segments | Outpatient Rehabilitation	'	'	'	'	'
Segment Information	'	'	'	'	'
Number of operating segments	'	'	2	'	'
Summary of selected financial data	'	'	'	'	'
Net operating revenues	190,223	182,246	579,404	566,195	'
Adjusted EBITDA	21,619	20,354	70,506	68,669	'
Total assets:	445,729	431,310	445,729	431,310	'
Capital expenditures	2,802	3,073	8,646	9,786	'
Operating Segments | Outpatient Rehabilitation | Select Medical Corporation	'	'	'	'	'
Summary of selected financial data	'	'	'	'	'
Total assets:	445,729	431,310	445,729	431,310	'
Other	'	'	'	'	'
Summary of selected financial data	'	'	'	'	'
Net operating revenues	12	14	322	111	'
Adjusted EBITDA	-16,471	-16,266	-49,059	-47,358	'
Total assets:	163,939	185,250	163,939	185,250	'
Capital expenditures	410	1,900	1,428	3,439	'
Other | Select Medical Corporation	'	'	'	'	'
Summary of selected financial data	'	'	'	'	'
Total assets:	$163,939	$184,120	$163,939	$184,120	'

Segment_Information_Details_2

Segment Information (Details 2) (USD $)	3 Months Ended			9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Mar. 31, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Segment Information	'	'	'	'	'
Adjusted EBITDA	$80,428	'	$87,747	$286,467	$307,090
Depreciation and amortization	-16,163	'	-15,537	-47,872	-47,164
Income from operations	62,399	'	70,819	233,192	255,936
Equity in earnings (losses) of unconsolidated subsidiaries	-179	'	1,167	1,447	6,384
Loss on early retirement of debt	'	-1,500	-6,064	-18,747	-6,064
Interest expense	-21,252	'	-24,575	-66,614	-72,295
Income before income taxes	40,968	'	41,347	149,278	183,961
Select Medical Corporation	'	'	'	'	'
Segment Information	'	'	'	'	'
Depreciation and amortization	-16,163	'	-15,537	-47,872	-47,164
Income from operations	62,399	'	70,819	233,192	255,936
Equity in earnings (losses) of unconsolidated subsidiaries	-179	'	1,167	1,447	6,384
Loss on early retirement of debt	'	'	-6,064	-17,788	-6,064
Interest expense	-21,252	'	-21,740	-64,204	-63,947
Income before income taxes	40,968	'	44,182	152,647	192,309
Operating Segments | Specialty Hospitals	'	'	'	'	'
Segment Information	'	'	'	'	'
Adjusted EBITDA	75,280	'	83,659	265,020	285,779
Depreciation and amortization	-12,267	'	-11,553	-36,061	-34,875
Income from operations	63,013	'	72,106	228,959	250,904
Operating Segments | Outpatient Rehabilitation	'	'	'	'	'
Segment Information	'	'	'	'	'
Adjusted EBITDA	21,619	'	20,354	70,506	68,669
Depreciation and amortization	-2,979	'	-3,152	-8,949	-10,034
Income from operations	18,640	'	17,202	61,557	58,635
Other	'	'	'	'	'
Segment Information	'	'	'	'	'
Adjusted EBITDA	-16,471	'	-16,266	-49,059	-47,358
Depreciation and amortization	-917	'	-832	-2,862	-2,255
Stock compensation expense	-1,866	'	-1,391	-5,403	-3,990
Income from operations	($19,254)	'	($18,489)	($57,324)	($53,603)

Income_per_Common_Share_Detail

Income per Common Share (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Numerator:	'	'	'	'
Net income attributable to Select Medical Holdings Corporation	$23,272	$24,110	$85,470	$108,824
Less: Earnings allocated to unvested restricted stockholders	497	407	1,802	1,759
Net income available to common stockholders	$22,775	$23,703	$83,668	$107,065
Denominator:	'	'	'	'
Weighted average shares - basic	136,646	137,551	136,879	139,138
Effect of dilutive securities: Stock options (in shares)	147	337	161	266
Weighted average shares - diluted	136,793	137,888	137,040	139,404
Income per common share	'	'	'	'
Basic income per common share (in dollars per share)	$0.17	$0.17	$0.61	$0.77
Diluted income per common share (in dollars per share)	$0.17	$0.17	$0.61	$0.77
Anti-dilutive securities excluded from computation of earnings per share	'	'	'	'
Stock options (in shares)	1,477	78	1,528	1,683

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (USD $)	Sep. 30, 2013	Sep. 25, 2013	Jun. 26, 2013	Mar. 29, 2013	Jan. 08, 2013	Sep. 30, 2013	Sep. 30, 2013
In Millions, unless otherwise specified		SSH-Evansville	SSH-Evansville	SSH-Evansville	SSH-Evansville	Professional liability claims	General liability claims
		Amended complaint	Amended complaint	Amended complaint	Amended complaint
					item
Commitments and Contingencies	'	'	'	'	'	'	'
Self insurance retention per occurrence	'	'	'	'	'	$2	$2
Number of case managers identified as plaintiff	'	'	'	'	2	'	'
Number of physicians named as defendants	'	'	'	'	2	'	'
Number of alleged receipts of separate Medicare payments	'	'	'	'	2	'	'
Number of days the deadlines have been stayed from the Magistrate judge	'	'	'	'90 days	'	'	'
Number of additional days the deadlines had been requested to be stayed	'	'90 days	'90 days	'	'	'	'
Construction Commitments	'	'	'	'	'	'	'
Outstanding commitments under construction contracts	$15.30	'	'	'	'	'	'

Subsequent_Event_Details

Subsequent Event (Details) (Subsequent Event, USD $)	0 Months Ended
	Oct. 30, 2013
Subsequent Event	'
Subsequent Event	'
Cash dividend declared (in dollars per share)	$0.10

Financial_Information_for_Subs2

Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 6.375% Senior Notes (Details) (6.375% senior notes)	Sep. 30, 2013
Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 6.375% Senior Notes	'
Interest rate of debt (as a percent)	6.38%
Select	'
Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 6.375% Senior Notes	'
Interest rate of debt (as a percent)	6.38%

Financial_Information_for_Subs3

Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 6.375% Senior Notes (Details 2) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified
Current Assets:	'	'	'	'
Cash and cash equivalents	$9,293	$40,144	$49,676	$12,043
Accounts receivable, net	423,334	359,929	'	'
Current deferred tax asset	15,372	17,877	'	'
Prepaid income taxes	4,044	3,895	'	'
Other current assets	39,968	31,818	'	'
Total Current Assets	492,011	453,663	'	'
Property and equipment, net	499,531	501,552	'	'
Goodwill	1,641,836	1,640,534	'	'
Other identifiable intangibles	71,831	71,745	'	'
Other assets	137,215	93,867	'	'
Total Assets	2,842,424	2,761,361	2,781,808	'
Current Liabilities:	'	'	'	'
Bank overdrafts	7,435	17,836	'	'
Current portion of long-term debt and notes payable	13,966	11,646	'	'
Accounts payable	96,360	89,547	'	'
Accrued payroll	81,303	88,586	'	'
Accrued vacation	57,328	55,714	'	'
Accrued interest	22,005	22,016	'	'
Accrued other	102,925	102,040	'	'
Due to third party payors	3,968	1,078	'	'
Total Current Liabilities	385,290	388,463	'	'
Long-term debt, net of current portion	1,474,915	1,458,597	'	'
Non-current deferred tax liability	90,859	89,510	'	'
Other non-current liabilities	80,077	68,502	'	'
Total Liabilities	2,031,141	2,005,072	'	'
Redeemable non-controlling interests	11,623	10,811	'	'
Stockholder's Equity:	'	'	'	'
Common stock	140	141	'	'
Capital in excess of par	472,080	473,697	'	'
Retained earnings (accumulated deficit)	296,196	243,210	'	'
Total Select Medical Holdings Corporation and Select Medical Corporation Stockholders' Equity	768,416	717,048	'	'
Non-controlling interests	31,244	28,430	'	'
Total Equity	799,660	745,478	'	'
Total Liabilities and Equity	2,842,424	2,761,361	'	'
Select Medical Corporation	'	'	'	'
Current Assets:	'	'	'	'
Cash and cash equivalents	9,293	40,144	49,676	12,043
Accounts receivable, net	423,334	359,929	'	'
Current deferred tax asset	15,372	17,877	'	'
Prepaid income taxes	4,044	3,895	'	'
Other current assets	39,968	31,818	'	'
Total Current Assets	492,011	453,663	'	'
Property and equipment, net	499,531	501,552	'	'
Goodwill	1,641,836	1,640,534	'	'
Other identifiable intangibles	71,831	71,745	'	'
Other assets	137,215	92,819	'	'
Total Assets	2,842,424	2,760,313	2,780,678	'
Current Liabilities:	'	'	'	'
Bank overdrafts	7,435	17,836	'	'
Current portion of long-term debt and notes payable	13,966	11,646	'	'
Accounts payable	96,360	89,547	'	'
Accrued payroll	81,303	88,586	'	'
Accrued vacation	57,328	55,714	'	'
Accrued interest	22,005	18,759	'	'
Accrued other	102,925	107,280	'	'
Due to third party payors	3,968	1,078	'	'
Total Current Liabilities	385,290	390,446	'	'
Long-term debt, net of current portion	1,474,915	1,291,297	'	'
Non-current deferred tax liability	90,859	89,510	'	'
Other non-current liabilities	80,077	68,502	'	'
Total Liabilities	2,031,141	1,839,755	'	'
Redeemable non-controlling interests	11,623	10,811	'	'
Stockholder's Equity:	'	'	'	'
Common stock	0	0	'	'
Capital in excess of par	866,423	859,839	'	'
Retained earnings (accumulated deficit)	-98,007	21,478	'	'
Total Select Medical Holdings Corporation and Select Medical Corporation Stockholders' Equity	768,416	881,317	'	'
Non-controlling interests	31,244	28,430	'	'
Total Equity	799,660	909,747	'	'
Total Liabilities and Equity	2,842,424	2,760,313	'	'
Select Medical Corporation | Reportable legal entities | Select Medical Corporation (Parent Company Only)	'	'	'	'
Current Assets:	'	'	'	'
Cash and cash equivalents	5,052	35,070	45,069	11,427
Current deferred tax asset	8,038	12,383	'	'
Prepaid income taxes	4,044	3,895	'	'
Other current assets	8,325	5,600	'	'
Total Current Assets	25,459	56,948	'	'
Property and equipment, net	14,911	16,344	'	'
Investment in affiliates	3,024,968	2,930,022	'	'
Non-current deferred tax asset	8,097	5,107	'	'
Other assets	36,509	28,680	'	'
Total Assets	3,109,944	3,037,101	'	'
Current Liabilities:	'	'	'	'
Bank overdrafts	7,435	17,836	'	'
Current portion of long-term debt and notes payable	9,467	8,916	'	'
Accounts payable	7,554	4,674	'	'
Intercompany accounts	1,135,472	1,124,173	'	'
Accrued payroll	516	186	'	'
Accrued vacation	4,502	4,249	'	'
Accrued interest	20,783	17,955	'	'
Accrued other	52,028	58,650	'	'
Total Current Liabilities	1,237,757	1,236,639	'	'
Long-term debt, net of current portion	1,048,053	872,671	'	'
Other non-current liabilities	55,718	46,474	'	'
Total Liabilities	2,341,528	2,155,784	'	'
Stockholder's Equity:	'	'	'	'
Common stock	0	0	'	'
Capital in excess of par	866,423	859,839	'	'
Retained earnings (accumulated deficit)	-98,007	21,478	'	'
Total Select Medical Holdings Corporation and Select Medical Corporation Stockholders' Equity	768,416	881,317	'	'
Total Equity	768,416	881,317	'	'
Total Liabilities and Equity	3,109,944	3,037,101	'	'
Select Medical Corporation | Reportable legal entities | Subsidiary Guarantors	'	'	'	'
Current Assets:	'	'	'	'
Cash and cash equivalents	2,996	3,734	3,535	'
Accounts receivable, net	360,805	308,043	'	'
Current deferred tax asset	2,945	1,060	'	'
Intercompany receivables	1,034,542	1,021,479	'	'
Other current assets	26,783	19,655	'	'
Total Current Assets	1,428,071	1,353,971	'	'
Property and equipment, net	426,915	425,677	'	'
Investment in affiliates	80,282	82,475	'	'
Goodwill	1,641,836	1,640,534	'	'
Other identifiable intangibles	71,831	71,745	'	'
Other assets	100,113	63,447	'	'
Total Assets	3,749,048	3,637,849	'	'
Current Liabilities:	'	'	'	'
Current portion of long-term debt and notes payable	1,918	1,059	'	'
Accounts payable	75,452	72,213	'	'
Accrued payroll	80,527	88,096	'	'
Accrued vacation	45,567	44,508	'	'
Accrued interest	1,222	804	'	'
Accrued other	41,525	39,876	'	'
Due to third party payors	733	'	'	'
Total Current Liabilities	246,944	246,556	'	'
Long-term debt, net of current portion	367,232	358,104	'	'
Non-current deferred tax liability	89,222	85,287	'	'
Other non-current liabilities	23,028	20,275	'	'
Total Liabilities	726,426	710,222	'	'
Stockholder's Equity:	'	'	'	'
Retained earnings (accumulated deficit)	886,099	790,692	'	'
Subsidiary investment	2,136,523	2,136,935	'	'
Total Select Medical Holdings Corporation and Select Medical Corporation Stockholders' Equity	3,022,622	2,927,627	'	'
Total Equity	3,022,622	2,927,627	'	'
Total Liabilities and Equity	3,749,048	3,637,849	'	'
Select Medical Corporation | Reportable legal entities | Non-Guarantor Subsidiaries	'	'	'	'
Current Assets:	'	'	'	'
Cash and cash equivalents	1,245	1,340	1,072	616
Accounts receivable, net	62,529	53,531	'	'
Current deferred tax asset	4,389	4,434	'	'
Intercompany receivables	100,930	102,694	'	'
Other current assets	4,860	6,563	'	'
Total Current Assets	173,953	168,562	'	'
Property and equipment, net	57,705	59,531	'	'
Other assets	593	692	'	'
Total Assets	232,251	228,785	'	'
Current Liabilities:	'	'	'	'
Current portion of long-term debt and notes payable	2,581	1,671	'	'
Accounts payable	13,354	12,660	'	'
Accrued payroll	260	304	'	'
Accrued vacation	7,259	6,957	'	'
Accrued other	9,372	8,754	'	'
Due to third party payors	3,235	2,723	'	'
Total Current Liabilities	36,061	33,069	'	'
Long-term debt, net of current portion	59,630	60,522	'	'
Non-current deferred tax liability	9,734	9,330	'	'
Other non-current liabilities	1,331	1,753	'	'
Total Liabilities	106,756	104,674	'	'
Redeemable non-controlling interests	11,623	10,811	'	'
Stockholder's Equity:	'	'	'	'
Retained earnings (accumulated deficit)	18,438	21,197	'	'
Subsidiary investment	64,190	63,673	'	'
Total Select Medical Holdings Corporation and Select Medical Corporation Stockholders' Equity	82,628	84,870	'	'
Non-controlling interests	31,244	28,430	'	'
Total Equity	113,872	113,300	'	'
Total Liabilities and Equity	232,251	228,785	'	'
Select Medical Corporation | Eliminations	'	'	'	'
Current Assets:	'	'	'	'
Accounts receivable, net	'	-1,645	'	'
Intercompany receivables	-1,135,472	-1,124,173	'	'
Total Current Assets	-1,135,472	-1,125,818	'	'
Investment in affiliates	-3,105,250	-3,012,497	'	'
Non-current deferred tax asset	-8,097	-5,107	'	'
Total Assets	-4,248,819	-4,143,422	'	'
Current Liabilities:	'	'	'	'
Intercompany accounts	-1,135,472	-1,124,173	'	'
Due to third party payors	'	-1,645	'	'
Total Current Liabilities	-1,135,472	-1,125,818	'	'
Non-current deferred tax liability	-8,097	-5,107	'	'
Total Liabilities	-1,143,569	-1,130,925	'	'
Stockholder's Equity:	'	'	'	'
Retained earnings (accumulated deficit)	-904,537	-811,889	'	'
Subsidiary investment	-2,200,713	-2,200,608	'	'
Total Select Medical Holdings Corporation and Select Medical Corporation Stockholders' Equity	-3,105,250	-3,012,497	'	'
Total Equity	-3,105,250	-3,012,497	'	'
Total Liabilities and Equity	($4,248,819)	($4,143,422)	'	'

Financial_Information_for_Subs4

Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 6.375% Senior Notes (Details 3) (USD $)	3 Months Ended			9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Mar. 31, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Consolidating Statement of Operations	'	'	'	'	'
Net operating revenues	$722,845	'	$713,669	$2,229,473	$2,207,883
Costs and expenses:	'	'	'	'	'
Cost of services	617,281	'	598,984	1,867,915	1,823,272
General and administrative	17,740	'	17,130	53,065	49,908
Bad debt expense	9,262	'	11,199	27,429	31,603
Depreciation and amortization	16,163	'	15,537	47,872	47,164
Total costs and expenses	660,446	'	642,850	1,996,281	1,951,947
Income from operations	62,399	'	70,819	233,192	255,936
Other income and expense:	'	'	'	'	'
Loss on early retirement of debt	'	-1,500	-6,064	-18,747	-6,064
Equity in earnings (losses) of unconsolidated subsidiaries	-179	'	1,167	1,447	6,384
Interest expense	-21,252	'	-24,575	-66,614	-72,295
Income before income taxes	40,968	'	41,347	149,278	183,961
Income tax expense (benefit)	15,761	'	16,189	57,391	71,415
Net income	25,207	'	25,158	91,887	112,546
Less: Net income attributable to non-controlling interests	1,935	'	1,048	6,417	3,722
Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation	23,272	'	24,110	85,470	108,824
Select Medical Corporation	'	'	'	'	'
Consolidating Statement of Operations	'	'	'	'	'
Net operating revenues	722,845	'	713,669	2,229,473	2,207,883
Costs and expenses:	'	'	'	'	'
Cost of services	617,281	'	598,984	1,867,915	1,823,272
General and administrative	17,740	'	17,130	53,065	49,908
Bad debt expense	9,262	'	11,199	27,429	31,603
Depreciation and amortization	16,163	'	15,537	47,872	47,164
Total costs and expenses	660,446	'	642,850	1,996,281	1,951,947
Income from operations	62,399	'	70,819	233,192	255,936
Other income and expense:	'	'	'	'	'
Loss on early retirement of debt	'	'	-6,064	-17,788	-6,064
Equity in earnings (losses) of unconsolidated subsidiaries	-179	'	1,167	1,447	6,384
Interest expense	-21,252	'	-21,740	-64,204	-63,947
Income before income taxes	40,968	'	44,182	152,647	192,309
Income tax expense (benefit)	15,761	'	17,181	58,570	74,337
Net income	25,207	'	27,001	94,077	117,972
Less: Net income attributable to non-controlling interests	1,935	'	1,048	6,417	3,722
Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation	23,272	'	25,953	87,660	114,250
Select Medical Corporation | Reportable legal entities | Select Medical Corporation (Parent Company Only)	'	'	'	'	'
Consolidating Statement of Operations	'	'	'	'	'
Net operating revenues	12	'	14	322	111
Costs and expenses:	'	'	'	'	'
Cost of services	608	'	544	1,718	1,554
General and administrative	17,696	'	17,742	52,915	51,197
Depreciation and amortization	917	'	832	2,862	2,255
Total costs and expenses	19,221	'	19,118	57,495	55,006
Income from operations	-19,209	'	-19,104	-57,173	-54,895
Other income and expense:	'	'	'	'	'
Intercompany interest and royalty fees	-278	'	-469	-1,033	-2,025
Intercompany management fees	32,621	'	34,811	114,597	91,940
Loss on early retirement of debt	'	'	-6,064	-17,788	-6,064
Interest expense	-14,192	'	-14,676	-44,345	-40,823
Income before income taxes	-1,058	'	-5,502	-5,742	-11,867
Income tax expense (benefit)	44	'	-3,589	1,956	-1,613
Equity in earnings of subsidiaries	24,374	'	27,866	95,358	124,504
Net income	23,272	'	25,953	87,660	114,250
Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation	23,272	'	25,953	87,660	114,250
Select Medical Corporation | Reportable legal entities | Subsidiary Guarantors	'	'	'	'	'
Consolidating Statement of Operations	'	'	'	'	'
Net operating revenues	617,415	'	616,610	1,913,597	1,910,563
Costs and expenses:	'	'	'	'	'
Cost of services	526,198	'	514,136	1,599,493	1,567,080
General and administrative	44	'	-612	150	-1,289
Bad debt expense	7,563	'	9,525	22,485	27,199
Depreciation and amortization	12,831	'	12,372	37,856	37,952
Total costs and expenses	546,636	'	535,421	1,659,984	1,630,942
Income from operations	70,779	'	81,189	253,613	279,621
Other income and expense:	'	'	'	'	'
Intercompany interest and royalty fees	310	'	459	1,051	1,998
Intercompany management fees	-27,386	'	-29,960	-100,005	-78,202
Equity in earnings (losses) of unconsolidated subsidiaries	-196	'	1,146	1,375	6,340
Interest expense	-6,031	'	-6,010	-16,800	-19,920
Income before income taxes	37,476	'	46,824	139,234	189,837
Income tax expense (benefit)	15,218	'	21,020	55,900	75,924
Equity in earnings of subsidiaries	1,952	'	2,123	12,073	11,234
Net income	24,210	'	27,927	95,407	125,147
Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation	24,210	'	27,927	95,407	125,147
Select Medical Corporation | Reportable legal entities | Non-Guarantor Subsidiaries	'	'	'	'	'
Consolidating Statement of Operations	'	'	'	'	'
Net operating revenues	105,418	'	97,045	315,554	297,209
Costs and expenses:	'	'	'	'	'
Cost of services	90,475	'	84,304	266,704	254,638
Bad debt expense	1,699	'	1,674	4,944	4,404
Depreciation and amortization	2,415	'	2,333	7,154	6,957
Total costs and expenses	94,589	'	88,311	278,802	265,999
Income from operations	10,829	'	8,734	36,752	31,210
Other income and expense:	'	'	'	'	'
Intercompany interest and royalty fees	-32	'	10	-18	27
Intercompany management fees	-5,235	'	-4,851	-14,592	-13,738
Equity in earnings (losses) of unconsolidated subsidiaries	17	'	21	72	44
Interest expense	-1,029	'	-1,054	-3,059	-3,204
Income before income taxes	4,550	'	2,860	19,155	14,339
Income tax expense (benefit)	499	'	-250	714	26
Net income	4,051	'	3,110	18,441	14,313
Less: Net income attributable to non-controlling interests	1,935	'	1,048	6,417	3,722
Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation	2,116	'	2,062	12,024	10,591
Select Medical Corporation | Eliminations	'	'	'	'	'
Other income and expense:	'	'	'	'	'
Equity in earnings of subsidiaries	-26,326	'	-29,989	-107,431	-135,738
Net income	-26,326	'	-29,989	-107,431	-135,738
Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation	($26,326)	'	($29,989)	($107,431)	($135,738)

Financial_Information_for_Subs5

Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 6.375% Senior Notes (Details 4) (USD $)	3 Months Ended			9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Mar. 31, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Operating activities	'	'	'	'	'
Net income	$25,207	'	$25,158	$91,887	$112,546
Adjustments to reconcile net income to net cash provided by operating activities:	'	'	'	'	'
Depreciation and amortization	16,163	'	15,537	47,872	47,164
Provision for bad debts	9,262	'	11,199	27,429	31,603
Equity in earnings of unconsolidated subsidiaries	179	'	-1,167	-1,447	-6,384
Loss on early retirement of debt	'	1,500	6,064	18,747	6,064
Loss (gain) from disposal of assets	'	'	'	-93	-3,484
Non-cash stock compensation expense	'	'	'	5,403	3,990
Amortization of debt discount and issuance costs	'	'	'	6,507	5,494
Changes in operating assets and liabilities, net of effects from acquisition of businesses:	'	'	'	'	'
Accounts receivable	'	'	'	-89,237	-10,507
Other current assets	'	'	'	-7,642	-1,849
Other assets	'	'	'	-3,211	1,270
Accounts payable	'	'	'	6,798	-4,098
Due to third-party payors	'	'	'	2,890	360
Accrued expenses	'	'	'	4,788	348
Income and deferred taxes	'	'	'	4,414	11,559
Net cash provided by operating activities	'	'	'	115,105	194,076
Investing activities	'	'	'	'	'
Purchases of property and equipment	-17,369	'	-17,254	-45,331	-45,188
Proceeds from sale of assets	'	'	'	518	16,511
Investment in business, net of distributions	'	'	'	-32,430	-9,899
Acquisition of businesses, net of cash acquired	'	'	'	-848	-1,547
Net cash used in investing activities	'	'	'	-78,091	-40,123
Financing activities	'	'	'	'	'
Borrowings on revolving credit facility	'	'	'	580,000	365,000
Payments on revolving credit facility	'	'	'	-645,000	-405,000
Borrowings on credit facility term loans, net of discount	'	'	'	298,500	266,750
Payments on credit facility term loans	'	'	'	-594,668	-7,063
Repurchase of 7 5/8% senior subordinated notes	'	'	'	-70,000	-278,495
Borrowings of other debt	'	'	'	9,238	5,835
Principal payments on other debt	'	'	'	-7,467	-7,417
Debt issuance costs	'	'	'	-18,820	-4,236
Dividends paid to Holdings	'	'	'	-27,929	'
Repayments of bank overdrafts	'	'	'	-10,401	-3,011
Distributions to non-controlling interests	'	'	'	-3,072	-2,997
Net cash used in financing activities	'	'	'	-67,865	-116,320
Net increase (decrease) in cash and cash equivalents	'	'	'	-30,851	37,633
Cash and cash equivalents at beginning of period	'	40,144	'	40,144	12,043
Cash and cash equivalents at end of period	9,293	'	49,676	9,293	49,676
Select Medical Corporation	'	'	'	'	'
Operating activities	'	'	'	'	'
Net income	25,207	'	27,001	94,077	117,972
Adjustments to reconcile net income to net cash provided by operating activities:	'	'	'	'	'
Depreciation and amortization	16,163	'	15,537	47,872	47,164
Provision for bad debts	9,262	'	11,199	27,429	31,603
Equity in earnings of unconsolidated subsidiaries	179	'	-1,167	-1,447	-6,384
Loss on early retirement of debt	'	'	6,064	17,788	6,064
Loss (gain) from disposal of assets	'	'	'	-93	-3,484
Non-cash stock compensation expense	'	'	'	5,403	3,990
Amortization of debt discount and issuance costs	'	'	'	6,418	5,215
Changes in operating assets and liabilities, net of effects from acquisition of businesses:	'	'	'	'	'
Accounts receivable	'	'	'	-89,237	-10,507
Other current assets	'	'	'	-7,642	-1,849
Other assets	'	'	'	-3,211	1,270
Accounts payable	'	'	'	6,798	-4,098
Due to third-party payors	'	'	'	2,890	360
Accrued expenses	'	'	'	8,046	2,956
Income and deferred taxes	'	'	'	5,593	14,481
Net cash provided by operating activities	'	'	'	120,684	204,753
Investing activities	'	'	'	'	'
Purchases of property and equipment	'	'	'	-45,331	-45,188
Proceeds from sale of assets	'	'	'	518	16,511
Investment in business, net of distributions	'	'	'	-32,430	-9,899
Acquisition of businesses, net of cash acquired	'	'	'	-848	-1,547
Net cash used in investing activities	'	'	'	-78,091	-40,123
Financing activities	'	'	'	'	'
Borrowings on revolving credit facility	'	'	'	580,000	365,000
Payments on revolving credit facility	'	'	'	-645,000	-405,000
Borrowings on credit facility term loans, net of discount	'	'	'	298,500	266,750
Payments on credit facility term loans	'	'	'	-594,668	-7,063
Issuance of 6.375% senior notes	'	'	'	600,000	'
Repurchase of 7 5/8% senior subordinated notes	'	'	'	-70,000	-278,495
Borrowings of other debt	'	'	'	9,238	5,835
Principal payments on other debt	'	'	'	-7,467	-7,417
Debt issuance costs	'	'	'	-18,820	-4,236
Dividends paid to Holdings	'	'	'	-211,754	-57,467
Equity investment by Holdings	'	'	'	'	1,104
Repayments of bank overdrafts	'	'	'	-10,401	-3,011
Distributions to non-controlling interests	'	'	'	-3,072	-2,997
Net cash used in financing activities	'	'	'	-73,444	-126,997
Net increase (decrease) in cash and cash equivalents	'	'	'	-30,851	37,633
Cash and cash equivalents at beginning of period	'	40,144	'	40,144	12,043
Cash and cash equivalents at end of period	9,293	'	49,676	9,293	49,676
Select Medical Corporation | Reportable legal entities | Select Medical Corporation (Parent Company Only)	'	'	'	'	'
Operating activities	'	'	'	'	'
Net income	23,272	'	25,953	87,660	114,250
Adjustments to reconcile net income to net cash provided by operating activities:	'	'	'	'	'
Depreciation and amortization	917	'	832	2,862	2,255
Loss on early retirement of debt	'	'	6,064	17,788	6,064
Non-cash stock compensation expense	'	'	'	5,403	3,990
Amortization of debt discount and issuance costs	'	'	'	6,418	5,215
Changes in operating assets and liabilities, net of effects from acquisition of businesses:	'	'	'	'	'
Equity in earnings of subsidiaries	-24,374	'	-27,866	-95,358	-124,504
Other current assets	'	'	'	-2,725	1,182
Other assets	'	'	'	-7,829	-604
Accounts payable	'	'	'	2,880	418
Accrued expenses	'	'	'	-3,211	3,870
Income and deferred taxes	'	'	'	5,593	14,481
Net cash provided by operating activities	'	'	'	19,481	26,617
Investing activities	'	'	'	'	'
Purchases of property and equipment	'	'	'	-1,428	-3,617
Net cash used in investing activities	'	'	'	-1,428	-3,617
Financing activities	'	'	'	'	'
Borrowings on revolving credit facility	'	'	'	580,000	365,000
Payments on revolving credit facility	'	'	'	-645,000	-405,000
Borrowings on credit facility term loans, net of discount	'	'	'	298,500	266,750
Payments on credit facility term loans	'	'	'	-594,668	-7,063
Issuance of 6.375% senior notes	'	'	'	600,000	'
Repurchase of 7 5/8% senior subordinated notes	'	'	'	-70,000	-278,495
Borrowings of other debt	'	'	'	8,154	5,557
Principal payments on other debt	'	'	'	-5,971	-6,667
Debt issuance costs	'	'	'	-18,820	-4,236
Dividends paid to Holdings	'	'	'	-211,754	-57,467
Equity investment by Holdings	'	'	'	'	1,104
Repayments of bank overdrafts	'	'	'	-10,401	-3,011
Intercompany	'	'	'	21,889	134,170
Net cash used in financing activities	'	'	'	-48,071	10,642
Net increase (decrease) in cash and cash equivalents	'	'	'	-30,018	33,642
Cash and cash equivalents at beginning of period	'	35,070	'	35,070	11,427
Cash and cash equivalents at end of period	5,052	'	45,069	5,052	45,069
Select Medical Corporation | Reportable legal entities | Subsidiary Guarantors	'	'	'	'	'
Operating activities	'	'	'	'	'
Net income	24,210	'	27,927	95,407	125,147
Adjustments to reconcile net income to net cash provided by operating activities:	'	'	'	'	'
Depreciation and amortization	12,831	'	12,372	37,856	37,952
Provision for bad debts	7,563	'	9,525	22,485	27,199
Equity in earnings of unconsolidated subsidiaries	196	'	-1,146	-1,375	-6,340
Loss (gain) from disposal of assets	'	'	'	25	-3,501
Changes in operating assets and liabilities, net of effects from acquisition of businesses:	'	'	'	'	'
Equity in earnings of subsidiaries	-1,952	'	-2,123	-12,073	-11,234
Accounts receivable	'	'	'	-75,295	7,296
Other current assets	'	'	'	-6,620	-2,141
Other assets	'	'	'	4,519	1,688
Accounts payable	'	'	'	3,224	-5,842
Due to third-party payors	'	'	'	2,378	-10,928
Accrued expenses	'	'	'	10,381	-1,912
Net cash provided by operating activities	'	'	'	80,912	157,384
Investing activities	'	'	'	'	'
Purchases of property and equipment	'	'	'	-39,101	-31,978
Proceeds from sale of assets	'	'	'	62	16,511
Investment in business, net of distributions	'	'	'	-32,430	-9,899
Acquisition of businesses, net of cash acquired	'	'	'	-848	-1,547
Net cash used in investing activities	'	'	'	-72,317	-26,913
Financing activities	'	'	'	'	'
Principal payments on other debt	'	'	'	-521	-322
Intercompany	'	'	'	-8,812	-126,614
Net cash used in financing activities	'	'	'	-9,333	-126,936
Net increase (decrease) in cash and cash equivalents	'	'	'	-738	3,535
Cash and cash equivalents at beginning of period	'	3,734	'	3,734	'
Cash and cash equivalents at end of period	2,996	'	3,535	2,996	3,535
Select Medical Corporation | Reportable legal entities | Non-Guarantor Subsidiaries	'	'	'	'	'
Operating activities	'	'	'	'	'
Net income	4,051	'	3,110	18,441	14,313
Adjustments to reconcile net income to net cash provided by operating activities:	'	'	'	'	'
Depreciation and amortization	2,415	'	2,333	7,154	6,957
Provision for bad debts	1,699	'	1,674	4,944	4,404
Equity in earnings of unconsolidated subsidiaries	-17	'	-21	-72	-44
Loss (gain) from disposal of assets	'	'	'	-118	17
Changes in operating assets and liabilities, net of effects from acquisition of businesses:	'	'	'	'	'
Accounts receivable	'	'	'	-13,942	-17,803
Other current assets	'	'	'	1,703	-890
Other assets	'	'	'	99	186
Accounts payable	'	'	'	694	1,326
Due to third-party payors	'	'	'	512	11,288
Accrued expenses	'	'	'	876	998
Net cash provided by operating activities	'	'	'	20,291	20,752
Investing activities	'	'	'	'	'
Purchases of property and equipment	'	'	'	-4,802	-9,593
Proceeds from sale of assets	'	'	'	456	'
Net cash used in investing activities	'	'	'	-4,346	-9,593
Financing activities	'	'	'	'	'
Borrowings of other debt	'	'	'	1,084	278
Principal payments on other debt	'	'	'	-975	-428
Intercompany	'	'	'	-13,077	-7,556
Distributions to non-controlling interests	'	'	'	-3,072	-2,997
Net cash used in financing activities	'	'	'	-16,040	-10,703
Net increase (decrease) in cash and cash equivalents	'	'	'	-95	456
Cash and cash equivalents at beginning of period	'	1,340	'	1,340	616
Cash and cash equivalents at end of period	1,245	'	1,072	1,245	1,072
Select Medical Corporation | Eliminations	'	'	'	'	'
Operating activities	'	'	'	'	'
Net income	-26,326	'	-29,989	-107,431	-135,738
Changes in operating assets and liabilities, net of effects from acquisition of businesses:	'	'	'	'	'
Equity in earnings of subsidiaries	$26,326	'	$29,989	$107,431	$135,738